论文信息 - ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death ACC/AHA TASK FORCE MEMBERS ESC COMMITTEE FOR PRACTICE GUIDELINES

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death ACC/AHA TASK FORCE MEMBERS ESC COMMITTEE FOR PRACTICE GUIDELINES

CC/AHA/ESC 2006 Guidelines for anagement of Patients With Ventricular rrhythmias and the Prevention of Sudden Cardiac Death Report of the American College of Cardiology/American eart Association Task Force and the European Society f Cardiology Committee for Practice Guidelines (Writing ommittee to Develop Guidelines for Management of Patients With entricular Arrhythmias and the Prevention of Sudden Cardiac Death) eveloped in Collaboration With the European Heart Rhythm ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.010

[1] J. Strasburger,et al. Complex ventricular ectopic activity in patients less than 20 years of age with or without syncope, and the role of ventricular extrastimulus testing. , 1991, The American journal of cardiology.

[2] Lippincott Williams Wilkins,et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[3] P. Sleight,et al. QT interval dynamics and heart rate variability preceding a case of cardiac arrest. , 1997, Heart.

[4] S. Connolly,et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[5] R. Kerber,et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[6] T. Wadden,et al. Long-term evaluation of cardiac function in obese patients treated with a very-low-calorie diet: a controlled clinical study of patients without underlying cardiac disease. , 1991, The American journal of clinical nutrition.

[7] Panos Vardas,et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. , 2004, European heart journal.

[8] P. Armstrong,et al. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. , 2003, Annals of internal medicine.

[9] A. Mahajan,et al. Use of thoracic epidural anesthesia for management of electrical storm: a case report. , 2005, Heart rhythm.

[10] A. Proclemer,et al. Right Ventricular Tachycardia with Left Bundle Branch Block and Inferior Axis Morphology: Clinical and Arrhythmological Characteristics in 15 Patients , 1989, Pacing and clinical electrophysiology : PACE.

[11] W. Edwards,et al. Sudden unexpected death in children and adolescents. , 1985, Journal of the American College of Cardiology.

[12] Sarah J Miller. Death resulting from overzealous total parenteral nutrition: the refeeding syndrome revisited. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[13] R. Thakur,et al. Lyme carditis: indications for cardiac pacing. , 1995, The Canadian journal of cardiology.

[14] R Yee,et al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. , 1999, Circulation.

[15] J. Kluger,et al. Mechanisms of syncope in implantable cardioverter-defibrillator recipients who receive device therapies. , 1998, The American journal of cardiology.

[16] W. Williams,et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. , 1997, Journal of the American College of Cardiology.

[17] A. Angelini,et al. No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy , 2000, Journal of clinical pathology.

[18] A. Sinusas,et al. Long QTc and Torsades de Pointes in Human Immunodeficiency Virus Disease , 1997, Pacing and clinical electrophysiology : PACE.

[19] G. Whipple,et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. , 1997, Medicine and science in sports and exercise.

[20] D. Levy,et al. Prognostic Implications of Asymptomatic Ventricular Arrhythmias: The Framingham Heart Study , 1992, Annals of Internal Medicine.

[21] B. Suys,et al. Dobutamine Stress Echocardiography in the Evaluation of Late Anthracycline Cardiotoxicity in Childhood Cancer Survivors , 1996, Pediatric Research.

[22] J. Bigger,et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[23] J. Mehta,et al. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. , 2003, The American journal of cardiology.

[24] Rabi Tawil,et al. Andersen's syndrome: Potassium‐sensitive periodic paralysis, ventricular ectopy, and dysmorphic features , 1994, Annals of neurology.

[25] P. Tchou,et al. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. , 1988, Circulation.

[26] J. Marín-García,et al. Cardiac manifestations of Rocky Mountain spotted fever. , 1981, Pediatrics.

[27] D. Wyse,et al. Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects. , 1989, Circulation.

[28] S. Behar,et al. Prognosis of early versus late ventricular fibrillation complicating acute myocardial infarction. , 1994, International journal of cardiology.

[29] M. Hocini,et al. Catheter Ablation of Ventricular Fibrillation in Structurally Normal Hearts Targeting the RVOT and Purkinje Ectopy , 2003, Herz.

[30] S. Priori,et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. , 1998, Circulation.

[31] S. Mittal. Sudden cardiac death in hypertrophic cardiomyopathy: risk evaluation. , 1995, International journal of cardiology.

[32] G. Sinagra,et al. Cardiac tamponade: an unusual, fatal complication of infective endocarditis. , 1999, Giornale italiano di cardiologia.

[33] S. Viskin,et al. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. , 1998, Progress in cardiovascular diseases.

[34] J. Ruskin,et al. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. , 1988, Journal of the American College of Cardiology.

[35] H. Wellens,et al. Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia. , 1997, The American journal of cardiology.

[36] G. von der Lippe,et al. Hypokalaemia and ventricular fibrillation in acute myocardial infarction. , 1983, British heart journal.

[37] W. Hobbie,et al. Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38] D. Roden,et al. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.

[39] A. Garson,et al. Ventricular couplets in the young: prognosis related to underlying substrate. , 1990, American heart journal.

[40] Antoine Leenhardt,et al. Hydroquinidine therapy in Brugada syndrome. , 2004, Journal of the American College of Cardiology.

[41] J. Brugada,et al. Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG , 2003, Circulation.

[42] L. Edvinsson,et al. Magnesium deficiency in coronary artery disease and cardiac arrhythmias , 1989, Journal of internal medicine.

[43] P. Gillette,et al. Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents. , 1996, Journal of the American College of Cardiology.

[44] J Thomas Bigger,et al. Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum , 2004, Circulation.

[45] A. Castellanos,et al. Community-Based Responses to Impending or Actual Cardiac Arrest and Advances in Post-Cardiac Arrest Care , 2003, Journal of Interventional Cardiac Electrophysiology.

[46] J. Manson,et al. Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.

[47] S. Hohnloser,et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. , 2002, Journal of the American College of Cardiology.

[48] G. De Backer,et al. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. , 1998, Journal of the American College of Cardiology.

[49] P Ducimetière,et al. Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[50] Paul J. Wang,et al. Inducible Ventricular Flutter and Fibrillation Predict for Arrhythmia Occurrence in Coronary Artery Disease Patients Presenting with Syncope of Unknown Origin , 2002, Journal of cardiovascular electrophysiology.

[51] R. Woosley,et al. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. , 1998, Journal of women's health.

[52] L. Hondeghem,et al. Antiarrhythmic agents: modulated receptor applications. , 1987, Circulation.

[53] A. Hallstrom,et al. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. , 2003, Journal of the American College of Cardiology.

[54] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[55] M. Holzer,et al. Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events. , 2002, Resuscitation.

[56] C. Pollick. Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide. , 1982, The New England journal of medicine.

[57] A. Garson,et al. Incessant ventricular tachycardia in infants: myocardial hamartomas and surgical cure. , 1987, Journal of the American College of Cardiology.

[58] Derick R. Peterson,et al. Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel , 2002, Circulation.

[59] M. Scheinman,et al. The 1998 NASPE Prospective Catheter Ablation Registry , 2000, Pacing and clinical electrophysiology : PACE.

[60] R. Liberthson,et al. Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[61] R. Wyse,et al. The natural and "unnatural" history of congenitally corrected transposition. , 1990, The American journal of cardiology.

[62] A. Moss,et al. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. , 1971, The New England journal of medicine.

[63] J. Hollifield. Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity. , 1989, The American journal of cardiology.

[64] M. Davies,et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[65] L. Weinstein. Life-threatening complications of infective endocarditis and their management. , 1986, Archives of internal medicine.

[66] D. Levy,et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[67] F. Morady,et al. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. , 1986, The American journal of cardiology.

[68] I. Tatsuno,et al. Octreotide improved ventricular arrhythmia in an acromegalic patient. , 2000, Endocrine journal.

[69] S. Viskin,et al. Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent? , 2000, Heart.

[70] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[71] Paul J. Wang,et al. Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators , 1997, Journal of Interventional Cardiac Electrophysiology.

[72] A. Moss,et al. Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction , 2004, Circulation.

[73] S. Swiryn,et al. Chronic recurrent right ventricular tachycardia in patients without ischemic heart disease: clinical, hemodynamic, and angiographic findings. , 1983, American heart journal.

[74] M. S. Freed,et al. Ventricular tachycardia in acute rheumatic fever. , 1985, Archives of internal medicine.

[75] M Egger,et al. Intravenous magnesium for acute myocardial infarction. , 2007, The Cochrane database of systematic reviews.

[76] C. Lambert,et al. Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. , 1994, The American journal of cardiology.

[77] J. Brugada,et al. Idiopathic Short QT Interval:A New Clinical Syndrome? , 2001, Cardiology.

[78] J. Ornato,et al. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US. , 2001, Resuscitation.

[79] Ric,et al. ELECTROPHYSIOLOGIC TESTING TO IDENTIFY PATIENTS WITH CORONARY ARTERY DISEASE WHO ARE AT RISK FOR SUDDEN DEATH , 2000 .

[80] S. Viskin,et al. Long-term prognosis of inducible ventricular flutter: not an innocent finding. , 2004, American heart journal.

[81] I. Olivotto,et al. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy. , 1999, Giornale italiano di cardiologia.

[82] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[83] L. Kuller,et al. Sudden and unexpected natural death in childhood and adolescence. , 1985, JAMA.

[84] H. Kennedy,et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. , 1994, The American journal of cardiology.

[85] B. Maron,et al. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.

[86] Ralph Lazzara,et al. Radiofrequency Catheter Ablation of Idiopathic Left Ventricular Tachycardia Guided by a Purkinje Potential , 1993, Circulation.

[87] A. G. Shaper,et al. Alcohol and sudden cardiac death , 1992, British heart journal.

[88] P. Tchou,et al. Ventricular Fibrillation: Ablation of a Trigger? , 2002, Journal of cardiovascular electrophysiology.

[89] J. Cleland,et al. Systematic review of the management of atrial fibrillation in patients with heart failure. , 2000, European heart journal.

[90] W. Wongcharoen,et al. Antiarrhythmic effects of n-3 polyunsaturated fatty acids. , 2005, Asia Pacific journal of clinical nutrition.

[91] R. Myerburg,et al. Sudden cardiac death. Magnitude of the problem, substrate/trigger interaction, and populations at high risk. , 1993, Cardiology Clinics.

[92] N. Benowitz,et al. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. , 2001, The New England journal of medicine.

[93] J. Colliver,et al. The electrocardiogram in obesity: statistical analysis of 1,029 patients. , 1986, Journal of the American College of Cardiology.

[94] Y. Tai,et al. Long‐term low‐dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: Efficacy and safety , 1997, Clinical cardiology.

[95] J. Bigger,et al. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. , 1997, The New England journal of medicine.

[96] T. Murohara,et al. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy. , 1999, The American journal of cardiology.

[97] U. V. von Oppell,et al. Surgery for ventricular tachycardia of left ventricular origin: risk factors for success and long-term outcome. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[98] M. Scheinman. NASPE Survey on Catheter Ablation , 1995, Pacing and clinical electrophysiology : PACE.

[99] C. Gruppi,et al. Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients. , 1999, American journal of hypertension.

[100] M. Brodsky,et al. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. , 2001, Journal of the American College of Cardiology.

[101] A. Burger,et al. Effect of Diabetes Mellitus on Heart Rate Variability in Patients with Congestive Heart Failure , 2001, Pacing and clinical electrophysiology : PACE.

[102] A. Camm,et al. Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. , 1994, The American journal of cardiology.

[103] J. Brugada,et al. Natural History of Brugada Syndrome: , 2003, Journal of cardiovascular electrophysiology.

[104] B. Milne,et al. Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[105] A. d'Avila,et al. A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory , 1996, Journal of cardiovascular electrophysiology.

[106] W. Mckenna,et al. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. , 1981, British heart journal.

[107] Y. Rosenberg,et al. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. , 1999, Circulation.

[108] J. Delaunay,et al. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. , 2005, In vivo.

[109] L. Rubin. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[110] W. Kou,et al. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. , 2001, Journal of the American College of Cardiology.

[111] L. Cobb,et al. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. , 1975, The New England journal of medicine.

[112] S. Priori,et al. Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.

[113] R. Gerszten,et al. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? , 1996, Journal of the American College of Cardiology.

[114] P. Kudenchuk,et al. Treatment of tachyarrhythmias. , 2001, Annals of emergency medicine.

[115] A. Castellanos,et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.

[116] W. Edwards,et al. Primary pulmonary hypertension: a histopathologic study of 80 cases. , 1985, Mayo Clinic proceedings.

[117] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[118] J. Videbaek,et al. [Serious arrhythmias in Borrelia infections]. , 1993, Ugeskrift for læger.

[119] J. Karjalainen,et al. Fever and cardiac rhythm. , 1986, Archives of internal medicine.

[120] C. Guilleminault,et al. Primary pulmonary hypertension with central sleep apnea: sudden death after bilevel positive airway pressure therapy. , 2000, Japanese circulation journal.

[121] S. Saksena,et al. Implantable Defibrillator Therapy for the Elderly. , 1998, The American journal of geriatric cardiology.

[122] B. Maron,et al. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. , 1992, The American journal of cardiology.

[123] I. Denjoy,et al. [Cardiac consequences of adolescent anorexia nervosa]. , 2001, Archives des maladies du coeur et des vaisseaux.

[124] A. J. Dunning,et al. Localization of the Site of Origin of Postinfarction Ventricular Tachycardia by Endocardial Pace Mapping Body Surface Mapping Compared With the 12‐Lead Electrocardiogram , 1993, Circulation.

[125] K. Lee,et al. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. , 2001, Journal of the American College of Cardiology.

[126] J. Hollifield,et al. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. , 1986, The American journal of medicine.

[127] P. Marzullo,et al. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study , 2002, Journal of endocrinological investigation.

[128] J. Brugada,et al. Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest , 2003, Circulation.

[129] K. Gowrishankar,et al. Varied manifestations of viral myocarditis , 1994, Indian journal of pediatrics.

[130] C A Warnes,et al. Challenges posed by adults with repaired congenital heart disease. , 2001, Circulation.

[131] R. Myerburg,et al. Sudden Cardiac Death: Exploring the Limits of Our Knowledge , 2001, Journal of cardiovascular electrophysiology.

[132] J. Mcanulty,et al. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger. , 1990, The American journal of cardiology.

[133] B. Lerman. Response of Nonreentrant Catecholamine‐ Mediated Ventricular Tachycardia to Endogenous Adenosine and Acetycholine Evidence for Myocardial Receptor‐Mediated Effects , 1993, Circulation.

[134] E. Negri,et al. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. , 1998, The American journal of cardiology.

[135] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[136] R. Dattwyler,et al. Ventricular tachycardia associated with Lyme carditis. , 1991, American heart journal.

[137] H. Wellens,et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. , 1999, Journal of clinical epidemiology.

[138] S B Heymsfield,et al. Anorexia nervosa and sudden death. , 1985, Annals of internal medicine.

[139] H. Mohri,et al. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia. , 1997, Internal medicine.

[140] E. Prystowsky,et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. , 1999, Journal of the American College of Cardiology.

[141] P. Kułakowski,et al. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[142] G. Billman,et al. Prevention of ischemia-induced cardiac Sudden death by n−3 polyunsaturated fatty acids in dogs , 1997, Lipids.

[143] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[144] W. Mckenna,et al. Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. , 1986, British heart journal.

[145] F. T. ten Cate,et al. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.

[146] D. Wolbrette,et al. Arrhythmias and women. , 1999, Current opinion in cardiology.

[147] S. Connolly,et al. Meta-analysis of antiarrhythmic drug trials. , 1999, The American journal of cardiology.

[148] P. Denes,et al. Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin. , 1988, Archives of internal medicine.

[149] J. Daubert,et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.

[150] P. Poole‐Wilson. Idiopathic dilated cardiomyopathy. , 1990, BMJ.

[151] S. Priori,et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. , 2004, JAMA.

[152] E. Antman,et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. , 1990, Circulation.

[153] J. Towbin,et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.

[154] R. Anderson,et al. Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings. , 1983, The American journal of cardiology.

[155] M. Burch,et al. Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[156] A. Skanes,et al. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. , 2002, The American journal of cardiology.

[157] Raimund Erbel,et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. , 2004, European heart journal.

[158] M. Silka,et al. Sudden Cardiac Death and the Use ofImplantable Cardioverter‐Defibrillators in Pediatric Patients , 1993, Circulation.

[159] R. Sung,et al. A LONGITUDINAL STUDY OF CARDIAC FUNCTION IN CHILDREN WITH CANCER OVER 40 MONTHS , 2000, Pediatric hematology and oncology.

[160] A. Castellanos,et al. Sudden cardiac death. Structure, function, and time-dependence of risk. , 1992, Circulation.

[161] J. Kriegsmann,et al. Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotes , 2001, Journal of Inherited Metabolic Disease.

[162] J. Brugada,et al. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[163] B. Surawicz,et al. Ectopic beats and atrioventricular conduction disturbances. In patients with hypopotassemia. , 1967, Archives of internal medicine.

[164] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.

[165] G. Blackwell,et al. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction. , 1998, American heart journal.

[166] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[167] J. Petrauskiene,et al. Daily variations in deaths in Lithuania: the possible contribution of binge drinking. , 2001, International journal of epidemiology.

[168] R. Svenson,et al. Brugada-type electrocardiographic pattern induced by cocaine. , 2000, Mayo Clinic proceedings.

[169] R. Franklin,et al. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[170] T. Cohen,et al. Complete heart block due to lyme carditis. , 2003, The Journal of invasive cardiology.

[171] J. Farré,et al. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials. , 1999, The American journal of cardiology.

[172] D. Zipes,et al. Use of Nonantiarrhythmic Drugs for Prevention of Sudden Cardiac Death , 2003, Journal of cardiovascular electrophysiology.

[173] A. Castellanos,et al. Clinical trials of implantable defibrillators. , 1997, The New England journal of medicine.

[174] A. Moss. MADIT-II: substudies and their implications. , 2003, Cardiac electrophysiology review.

[175] G. Quaglio,et al. Sudden death in Staphylococcus aureus-associated infective endocarditis due to perforation of a free-wall myocardial abscess. , 2001, Scandinavian journal of infectious diseases.

[176] W. Mckenna,et al. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. , 1995, Circulation.

[177] A. Garson,et al. Surgical treatment of ventricular tachycardia in infants. , 1984, The New England journal of medicine.

[178] M. Desai,et al. Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.

[179] S. Solomon,et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[180] T. Graboys,et al. Exercise stress testing in the management of cardiac rhythm disorders. , 1984, The Medical clinics of North America.

[181] Prashanthan Sanders,et al. Mapping and Ablation of Ventricular Fibrillation Associated With Long-QT and Brugada Syndromes , 2003, Circulation.

[182] G. Thiene,et al. [Cardiological protocols on evaluation of fitness for competitive sports]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[183] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[184] A. Parkhomenko,et al. Management of grown up congenital heart disease. , 2003, European heart journal.

[185] R. Virmani,et al. Pulmonary Arterial Dissections and Ruptures: To be Considered in Patients with Pulmonary Arterial Hypertension Presenting with Cardiogenic Shock or Sudden Death , 1990, Pathology.

[186] Y. Kimura,et al. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction. , 1995, Japanese circulation journal.

[187] D. Fatkin,et al. Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy. , 2001, The New England journal of medicine.

[188] K. Kuck,et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. , 1988, European heart journal.

[189] R. Gibbons,et al. Guidelines for the Management of Patients With Valvular Heart Disease Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease) , 1998 .

[190] H. Sakuraba,et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. , 1995, The New England journal of medicine.

[191] W. Stevenson,et al. Catheter ablation of ventricular tachycardia after myocardial infarction: relation of endocardial sinus rhythm late potentials to the reentry circuit. , 1996, Journal of the American College of Cardiology.

[192] W. Kannel,et al. Long- and short-term risk of sudden coronary death. , 1992, Circulation.

[193] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[194] J J de Lima,et al. [Emission computed tomography]. , 1980, Acta medica portuguesa.

[195] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[196] K. Olesen. THE NATURAL HISTORY OF 271 PATIENTS WITH MITRAL STENOSIS UNDER MEDICAL TREATMENT , 1962, British heart journal.

[197] T. Therneau,et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. , 1997, The New England journal of medicine.

[198] A. Jacobs,et al. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. , 1992, Journal of the American College of Cardiology.

[199] Ian G. Harnik. Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.

[200] Y Pawitan,et al. Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. , 1991, The American journal of cardiology.

[201] R. Elston,et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. , 2001, Circulation.

[202] A. Taylor,et al. Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. , 1994, The American journal of cardiology.

[203] M. Achtelik,et al. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period , 1997, Heart.

[204] S. Hohnloser,et al. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. , 1998, Journal of the American College of Cardiology.

[205] B. Merkely,et al. Clinical Experience with a New Detection Algorithm for Differentiation of Supraventricular from Ventricular Tachycardia in a Dual‐Chamber Defibrillator , 2004, Journal of cardiovascular electrophysiology.

[206] N. Sheard. Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.

[207] Yasuharu Matsumoto,et al. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. , 2005, Journal of the American College of Cardiology.

[208] P. Touboul,et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[209] M. Quadrel,et al. Delayed cardiotoxicity during treatment with intravenous pentamidine: two case reports and a review of the literature. , 1992, American heart journal.

[210] Diederick E Grobbee,et al. T axis as an indicator of risk of cardiac events in elderly people , 1998, The Lancet.

[211] D. F. Moore,et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. , 2001, JAMA.

[212] G. A. West,et al. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. , 1986, Circulation.

[213] Hue-Teh Shih,et al. Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients Without Structural Heart Disease , 1992, Circulation.

[214] M. Arruda,et al. Ablation of Epicardial Macroreentrant Ventricular Tachycardia Associated with Idiopathic Nonischemic Dilated Cardiomyopathy by a Percutaneous Transthoracic Approach , 2002, Journal of cardiovascular electrophysiology.

[215] B. Surawicz,et al. The enigma of sudden cardiac death related to dieting. , 1995, The Canadian journal of cardiology.

[216] J. Mcanulty,et al. Assessment and follow-up of pediatric survivors of sudden cardiac death. , 1990, Circulation.

[217] P. Schwartz,et al. Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations: Characteristic T-U–Wave Patterns Predict the KCNJ2 Genotype , 2005, Circulation.

[218] M. Lipton,et al. Determination of left ventricular mass with ultrafast CT and two-dimensional echocardiography. , 1989, Radiology.

[219] A. Kadish,et al. Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study. , 1989, Journal of the American College of Cardiology.

[220] A J Camm,et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. , 1991, Circulation.

[221] W. Roberts,et al. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.

[222] M. Copass,et al. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation , 1999, JAMA.

[223] G. Klein,et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. , 1989, The New England journal of medicine.

[224] A. Steere,et al. Lyme Carditis: Cardiac Abnormalities of Lyme Disease , 1980 .

[225] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[226] T. Paul,et al. [Q-fever associated myocarditis in a 14-year-old boy]. , 1995, Zeitschrift fur Kardiologie.

[227] E. Rapaport. Prehospital Ventricular Defibrillation , 1974 .

[228] M. Santini,et al. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[229] A. Becker,et al. Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. , 1975, The American journal of cardiology.

[230] G. Fonarow,et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. , 2000, The American journal of cardiology.

[231] F. Morady,et al. A prospective comparison of programmed ventricular stimulation with triple extrastimuli versus single and double extrastimuli during infusion of isoproterenol. , 1989, American heart journal.

[232] J. Lokich,et al. The syndrome of 5‐fluorouracil cardiotoxicity: An elusive cardiopathy , 1993, Cancer.

[233] R. Koster. Automatic External Defibrillator: Key Link in the Chain of Survival , 2002, Journal of cardiovascular electrophysiology.

[234] D. Warrell,et al. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital , 2000, Heart.

[235] E. V. Vaughan Williams. A classification of antiarrhythmic actions reassessed after a decade of new drugs. , 1984, Journal of clinical pharmacology.

[236] Pamela S Douglas,et al. Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[237] L. Mitchell,et al. Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. , 2002, Journal of the American College of Cardiology.

[238] C. Oakley,et al. Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy. , 1991, The American journal of cardiology.

[239] A. Hallstrom,et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. , 2001, Journal of cardiovascular electrophysiology.

[240] M. Borggrefe,et al. Clinical characteristics and treatment of short QT syndrome , 2005, Expert review of cardiovascular therapy.

[241] M. Fromer,et al. Algorithm for the prevention of ventricular tachycardia onset: the Prevent Study. , 1999, The American journal of cardiology.

[242] A. Camm,et al. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. , 1999, Circulation.

[243] G. Billman,et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. , 2003, Circulation.

[244] D. Lancet,et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.

[245] P. Brugada,et al. Experience with implantable cardioverter defibrillator therapy in elderly patients. , 1997, European heart journal.

[246] H. Wellens,et al. Ventricular tachycardia: diagnosis of broad QRS complex tachycardia , 2001, Heart.

[247] P. Armstrong,et al. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. , 1987, Archives of internal medicine.

[248] M. Cohen,et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. , 1991, Journal of the American College of Cardiology.

[249] Wu Shu-lin. Placebo-controlled,Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator , 2005 .

[250] P. Steinherz,et al. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. , 1995, Medical and pediatric oncology.

[251] B. Maron,et al. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. , 2005, Journal of the American College of Cardiology.

[252] E. Gang,et al. Mode of stimulation versus response: validation of a protocol for induction of ventricular tachycardia. , 1985, American heart journal.

[253] P. Dorian,et al. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[254] R. Swanton,et al. Mortality from infective endocarditis: clinical predictors of outcome , 2002, Heart.

[255] Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. , 2001, Journal of the American College of Cardiology.

[256] M. Schmitt,et al. Aortic valve endocarditis causing fatal myocardial infarction caused by ostial coronary artery obliteration , 2004, Heart.

[257] P. Nihoyannopoulos,et al. Investigation of a Hemodynamic Basis for Syncope in Hypertrophic Cardiomyopathy: Use of a Head‐Up Tilt Test , 1992, Circulation.

[258] A. Oto,et al. Adrenal Adenoma Presenting with Torsade de Pointes , 2002, Angiology.

[259] K. Damus,et al. Trends in infant mortality attributable to birth defects--United States, 1980-1995. , 1998, MMWR. Morbidity and mortality weekly report.

[260] J. Merino,et al. Arrhythmias associated with neuromuscular disorders. , 2002, Cardiac electrophysiology review.

[261] M. Enriquez-Sarano,et al. Natural History of Asymptomatic Mitral Valve Prolapse in the Community , 2002, Circulation.

[262] R. Thakur,et al. Cardiac manifestations of Lyme disease: a review. , 1996, The Canadian journal of cardiology.

[263] H. Calkins,et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. , 2003, Circulation.

[264] T. Sacchi,et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. , 2003, International journal of cardiology.

[265] V. Rastogi,et al. Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.

[266] A Bhandari,et al. Electrophysiologic testing in bundle branch block and unexplained syncope. , 1984, The American journal of cardiology.

[267] M. Alpert. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. , 2001, The American journal of the medical sciences.

[268] S. Viskin,et al. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls , 2000, Heart.

[269] R. Gillum,et al. Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[270] J. Brugada,et al. Electrical storm in Brugada syndrome successfully treated using isoprenaline. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[271] J R Roelandt,et al. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. , 1993, British heart journal.

[272] R. Moosdorf. ICD Implantation with and without combined myocardial revascularization -- incidence of ICD therapy and late survival. , 2003, The Thoracic and cardiovascular surgeon.

[273] W. Mckenna,et al. Echocardiographic and histologic evaluation of the right ventricle in ventricular tachycardias of left bundle branch block morphology without overt cardiac abnormality. , 1989, The American journal of cardiology.

[274] C. Mewis,et al. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. , 1997, Journal of cardiovascular pharmacology.

[275] A. Murray,et al. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. , 1993, The Quarterly journal of medicine.

[276] M. Sketch,et al. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. , 1990, The American journal of cardiology.

[277] J. Brugada,et al. Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator. , 2002, European heart journal.

[278] P. Brugada,et al. Transcoronary chemical ablation of arrhythmias. , 1992, Pacing and clinical electrophysiology : PACE.

[279] G. V. Van Hare,et al. Ventricular tachycardia and accelerated ventricular rhythm presenting in the first month of life. , 1991, The American journal of cardiology.

[280] N. Mok,et al. Successful Use of Quinidine in Treatment of Electrical Storm in Brugada Syndrome , 2004, Pacing and clinical electrophysiology : PACE.

[281] P. Gillette,et al. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. , 1991, Journal of the American College of Cardiology.

[282] S. Rasheed,et al. Human immunodeficiency virus type 1 infection of the heart in three infants with acquired immunodeficiency syndrome and sudden death. , 1996, The Pediatric infectious disease journal.

[283] M. Josephson,et al. Right ventricular tachycardia: clinical and electrophysiologic characteristics. , 1983, Circulation.

[284] A. Kadish,et al. Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation , 2000, Pacing and clinical electrophysiology : PACE.

[285] R J Cohen,et al. T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers , 1998, Journal of cardiovascular electrophysiology.

[286] J. Sanderson,et al. Ablation of Nonsustained or Hemodynamically Unstable Ventricular Arrhythmia Originating From the Right Ventricular Outflow Tract Guided by Noncontact Mapping , 2003, Pacing and clinical electrophysiology : PACE.

[287] M. Meghji,et al. Toxoplasmic infection in cardiac disease. , 1979, The American journal of cardiology.

[288] W. Allan,et al. Long QT Syndrome , 1998, Pediatrics.

[289] S. Goldstein,et al. Characteristics of the Resuscitated Out‐of‐hospital Cardiac Arrest Victim with Coronary Heart Disease , 1981, Circulation.

[290] William H. Maisel,et al. Catheter Ablation in Patients With Multiple and Unstable Ventricular Tachycardias After Myocardial Infarction Short Ablation Lines Guided by Reentry Circuit Isthmuses and Sinus Rhythm Mapping , 2002 .

[291] P. Podrid. Potassium and ventricular arrhythmias. , 1990, The American journal of cardiology.

[292] L. Horowitz,et al. Surgical excision of automatic atrial tachycardia: anatomic and electrophysiologic correlates. , 1982, American heart journal.

[293] D. Battleman,et al. Mechanism of repetitive monomorphic ventricular tachycardia. , 1995, Circulation.

[294] S. Rahimtoola,et al. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. , 1992, American heart journal.

[295] G. Hufnagel,et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) First Epidemiological Results , 2000, Herz.

[296] S. Ratel,et al. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia--an autopsy study of 20 forensic cases. , 1998, Journal of forensic sciences.

[297] E. Davison,et al. Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia. , 1995, Journal of electrocardiology.

[298] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[299] J. Etherington,et al. Atrio-Ventricular Dissociation in Meningococcal Meningitis , 1995, Journal of the Royal Army Medical Corps.

[300] G. Gemme,et al. [RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. , 1963, La Clinica pediatrica.

[301] S. Connolly,et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[302] K. Neumärker. Mortality and sudden death in anorexia nervosa. , 1997, The International journal of eating disorders.

[303] V. Athyros,et al. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. , 1998, Acta cardiologica.

[304] J. Steinberger,et al. Causes of sudden unexpected cardiac death in the first two decades of life. , 1996, The American journal of cardiology.

[305] J. Hulting. In-hospital ventricular fibrillation and its relation to serum potassium. , 2009, Acta medica Scandinavica. Supplementum.

[306] A. Capucci,et al. ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. , 2004, European heart journal.

[307] D. Wilber,et al. Adenosine‐Sensitive Ventricular Tachycardia Clinical Characteristics and Response to Catheter Ablation , 1993, Circulation.

[308] R. Virmani,et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.

[309] S. Dixit,et al. Ventricular arrhythmias in normal hearts. , 2008, Cardiology clinics.

[310] R. Mulleneers,et al. The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. , 1989, European heart journal.

[311] M. Frenneaux,et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[312] W. Remme,et al. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. , 1991, American Heart Journal.

[313] Rose Anne Kenny,et al. Guidelines on management (diagnosis and treatment) of syncope--update 2004. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[314] E. Berbari,et al. The Signal‐Averaged Electrocardiogram: , 1996, Journal of cardiovascular electrophysiology.

[315] H. Crijns,et al. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. , 1988, The American journal of cardiology.

[316] K. Borch-Johnsen,et al. Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study , 2003, The Lancet.

[317] J. Soar,et al. European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support. , 2005, Resuscitation.

[318] A. Camm,et al. Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? , 1998, The American journal of cardiology.

[319] S. MacMahon,et al. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. , 1986, The New England journal of medicine.

[320] P. Kudenchuk,et al. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents. , 1990, The American journal of cardiology.

[321] M. Shenasa,et al. A critical reappraisal of serial electrophysiologic drug testing for sustained ventricular tachycardia. , 1987, American heart journal.

[322] P. Dorian,et al. An overview of the management of electrical storm. , 1997, The Canadian journal of cardiology.

[323] L Goldman,et al. Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction , 1997 .

[324] M. Brodsky,et al. New-onset ventricular tachycardia during pregnancy. , 1992, American heart journal.

[325] J. Ruskin,et al. Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. , 1999, Progress in cardiovascular diseases.

[326] A. Castellanos,et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[327] D. Keefe,et al. Clinical Cardiotoxicity of 5‐Fluorouracil , 1993, Journal of clinical pharmacology.

[328] X. Jouven,et al. Circulating Nonesterified Fatty Acid Level as a Predictive Risk Factor for Sudden Death in the Population , 2001, Circulation.

[329] J. Daubert,et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[330] W. Aronow,et al. Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[331] A. Keren,et al. Treatment of torsade de pointes with magnesium sulfate. , 1988, Circulation.

[332] H. Wellens,et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. , 1997, Journal of the American College of Cardiology.

[333] N. Molander. Sudden natural death in later childhood and adolescence. , 1982, Archives of disease in childhood.

[334] S. Ernst,et al. Successful Catheter Ablation of Electrical Storm After Myocardial Infarction , 2003, Circulation.

[335] Á. S. Liprandi,et al. Implantable Cardioverter Defibrillators in Patients with Chagas' Disease: Are They Different from Patients with Coronary Disease? , 1997, Pacing and clinical electrophysiology : PACE.

[336] E. Prystowsky,et al. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. , 1982, The American journal of cardiology.

[337] K. Kuck,et al. Successful Catheter Ablation of Human Ventricular Tachycardia with Radiofrequency Current Guided by an Endocardial Map of the Area of Slow Conduction , 1991, Pacing and clinical electrophysiology : PACE.

[338] D. Fatkin,et al. Molecular mechanisms of inherited cardiomyopathies. , 2002, Physiological reviews.

[339] Dudley J Pennell,et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[340] R. Virmani,et al. Sudden death as a result of heart disease in morbid obesity. , 1995, American heart journal.

[341] S. Dubner,et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. , 1996, Circulation.

[342] E. Behr,et al. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death , 2002, Heart.

[343] N. Hasebe,et al. A Case of a Short‐Coupled Variant of Torsades De Pointes with Electrical Storm , 2003, Pacing and clinical electrophysiology : PACE.

[344] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[345] L. Cohn,et al. Aortic valve endocarditis. Determinants of early survival and late morbidity. , 1994, Circulation.

[346] R. Speier,et al. Surgical treatment of active infective endocarditis with paravalvular involvement. , 1994, The Journal of thoracic and cardiovascular surgery.

[347] M. Naghavi,et al. Vulnerable Atherosclerotic Plaque: A Multifocal Disease , 2003, Circulation.

[348] Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 5: pharmacology I: agents for arrhythmias. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. , 2000, Circulation.

[349] Carlo Napolitano,et al. Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[350] W. Grimm,et al. Reversal of Tachycardia Induced Cardiomyopathy Following Ablation of Repetitive Monomorphic Right Ventricular Outflow Tract Tachycardia , 2001, Pacing and clinical electrophysiology : PACE.

[351] E. Ruiz,et al. Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. , 1987, The American journal of cardiology.

[352] J. Lima,et al. Cardiovascular magnetic resonance imaging: current and emerging applications. , 2004, Journal of the American College of Cardiology.

[353] M. Cucherat,et al. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. , 2002, American heart journal.

[354] J. A. Vázquez de Prada,et al. Perivalvular abscesses associated with endocarditis. Clinical features and diagnostic accuracy of two-dimensional echocardiography. , 1993, Chest.

[355] A. Tajik,et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[356] P. Schwartz,et al. Clinical problem-solving. QT or not QT? , 2000, The New England journal of medicine.

[357] A. S. Mary,et al. Ventricular tachycardia in a patient with toxoplasmosis. , 1973, British heart journal.

[358] A. Dyer,et al. Alcohol Consumption, Cardiovascular Risk Factors, and Mortality in Two Chicago Epidemiologic Studies , 1977, Circulation.

[359] F. Harrell,et al. Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease. , 1983, Journal of the American College of Cardiology.

[360] W J Manning,et al. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. , 2000, Journal of the American College of Cardiology.

[361] M. Domanski,et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. , 1998, American heart journal.

[362] R. Campbell,et al. ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[363] J. Kasell,et al. New Perspectives on Catheter-Based Ablation of Ventricular Tachycardia Complicating Chagas' Disease: Experimental Evidence of the Efficacy of Near Infrared Lasers for Catheter Ablation of Chagas' VT , 2002, Journal of Interventional Cardiac Electrophysiology.

[364] D. Moodie,et al. Primary pulmonary hypertension, then and now: 28 years of experience. , 1992, Cleveland Clinic journal of medicine.

[365] D J Roe,et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. , 2000, The New England journal of medicine.

[366] F. Triposkiadis,et al. Hypertrophic cardiomyopathy in Greece: clinical course and outcome. , 1998, Chest.

[367] T. Noshiro,et al. QT prolongation with torsade de pointes in pheochromocytoma. , 1992, American heart journal.

[368] J. Lyznicki,et al. Cardiovascular screening of student athletes. , 2000, American family physician.

[369] L. Cobb,et al. Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation. , 1982, JAMA.

[370] G. Klein,et al. Syncope Associated With Supraventricular Tachycardia: An Expression of Tachycardia Rate or Vasomotor Response? , 1992, Circulation.

[371] V. Esposito,et al. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients , 2001, Clinical endocrinology.

[372] JoAnn E. Manson,et al. Prospective Study of Sudden Cardiac Death Among Women in the United States , 2003, Circulation.

[373] G. Breithardt,et al. Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .

[374] R. Griggs,et al. Andersen's syndrome: A distinct periodic paralysis , 1997, Annals of neurology.

[375] D N Ross,et al. Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. , 1991, Journal of the American College of Cardiology.

[376] B. Maron,et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[377] A. di Lenarda,et al. Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. , 1994, British heart journal.

[378] M. Domanski,et al. Survival of Antiarrhythmic or Implantable Cardioverter Defibrillator Treated Patients with Varying Degrees of Left Ventricular Dysfunction Who Survived Malignant Ventricular Arrhythmias , 2002, Journal of cardiovascular electrophysiology.

[379] M. Scheinman,et al. Polymorphous Ventricular Tachycardia Associated With Acute Myocardial Infarction , 1991, Circulation.

[380] B. McManus,et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[381] J. Brugada,et al. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death--the Brugada syndrome. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[382] F. Dunn,et al. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. , 1984, The American journal of medicine.

[383] G Corrao,et al. Alcohol and coronary heart disease: a meta-analysis. , 2000, Addiction.

[384] J. Goldberg,et al. Ventricular Premature Complexes and Sudden Death After Myocardial Infarction , 1981, Circulation.

[385] D. Siscovick,et al. The incidence of primary cardiac arrest during vigorous exercise. , 1984, The New England journal of medicine.

[386] Atrick,et al. A COMPARISON OF REPEATED HIGH DOSES AND REPEATED STANDARD DOSES OF EPINEPHRINE FOR CARDIAC ARREST OUTSIDE THE HOSPITAL , 2000 .

[387] Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V1 to V3 , 2002 .

[388] G. Mancia,et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). , 2004, Atherosclerosis.

[389] B. Deal,et al. Ventricular tachycardia in a young population without overt heart disease. , 1986, Circulation.

[390] P. Coumel,et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[391] P. Cappabianca,et al. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. , 2001, The Journal of clinical endocrinology and metabolism.

[392] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[393] T. Raghunathan,et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[394] H. Zwerling. Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient? , 1987, American heart journal.

[395] M. Nagashima,et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death , 2003, Heart.

[396] A. Camm,et al. Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. , 1993, American heart journal.

[397] T. N. James,et al. Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. , 1962, American heart journal.

[398] M. Okajima,et al. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG monitoring , 2005, Pediatric Cardiology.

[399] B. Brembilla-Perrot,et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. , 1991, American heart journal.

[400] A. Angelini,et al. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. , 1999, The American journal of cardiology.

[401] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[402] M. Terpenning. Infective endocarditis. , 1992, Clinics in geriatric medicine.

[403] H Calkins,et al. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. , 1991, Journal of the American College of Cardiology.

[404] L. Thierfelder,et al. Heart failure in arrhythmogenic right ventricular dysplasia-cardiomyopathy. , 1999, International journal of cardiology.

[405] A. Camm,et al. Efficacy of Automatic Multimodal Device Therapy for Ventricular Tachyarrhythmias as Delivered by a New Implantable Pacing Cardioverter‐Defibrillator: Results of a European Multicenter Study of 102 Implants , 1992, Circulation.

[406] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[407] T. Walczak. Do Antiepileptic Drugs Play a Role in Sudden Unexpected Death in Epilepsy? , 2003, Drug safety.

[408] B. Maron,et al. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[409] Paul J. Wang,et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. , 2002, Mayo Clinic proceedings.

[410] W. Hua,et al. Radiofrequency ablation of idiopathic ventricular tachycardia. , 1996, Australian and New Zealand journal of medicine.

[411] S. Hohnloser,et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. , 1999, The New England journal of medicine.

[412] M. Josephson,et al. Nonsustained Ventricular Tachycardia in Coronary Artery Disease: Relation to Inducible Sustained Ventricular Tachycardia , 1996, Annals of Internal Medicine.

[413] J Thomas Bigger,et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.

[414] R. Hauer,et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). , 1999, Journal of the American College of Cardiology.

[415] M. Josephson,et al. Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. , 1999, Circulation.

[416] K. Murray,et al. Relationship between area deprivation and the anticaries benefit of an oral health programme providing free fluoride toothpaste to young children. , 2004, Community dentistry and oral epidemiology.

[417] R. Goldberg,et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. , 1993, The New England journal of medicine.

[418] T. Inoshita,et al. Sudden death from pericardial tamponade. Unusual complication of nonbacterial thrombotic endocarditis. , 1985, Archives of pathology & laboratory medicine.

[419] C. Wren,et al. Sudden death in children and adolescents , 2000, Heart.

[420] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[421] C. Lau,et al. Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis. , 1992, Cardiology.

[422] J. Bourke,et al. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. , 2003, European heart journal.

[423] S. Pringle,et al. Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation. , 1990, American heart journal.

[424] E. Sacanella,et al. Comparison of alcoholic cardiomyopathy in women versus men. , 1997, The American journal of cardiology.

[425] M. Lehmann,et al. Sex difference in risk of torsade de pointes with d,l-sotalol. , 1996, Circulation.

[426] P. Steen,et al. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. , 2003, JAMA.

[427] E. Drenick,et al. Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy. , 1988, American Journal of Surgery.

[428] J. Schläpfer,et al. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up. , 2002, Journal of the American College of Cardiology.

[429] R. Bonow,et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). , 1987, The New England journal of medicine.

[430] A. Yokoyama,et al. A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves. , 1987, British heart journal.

[431] H Hayashi,et al. [Signal-averaged electrocardiogram]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[432] B. Gersh,et al. The Clinical Course of Idiopathic Dilated Cardiomyopathy , 1992, Annals of Internal Medicine.

[433] A. Kadish,et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. , 1993, The American journal of cardiology.

[434] L. Sjöström. Mortality of severely obese subjects. , 1992, The American journal of clinical nutrition.

[435] K. Kuck,et al. Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) , 2002, Circulation.

[436] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[437] W. Kannel,et al. The epidemiology of sudden unexpected death: risk factors for men and women in the Framingham Heart Study. , 1984, American heart journal.

[438] D. Zipes,et al. Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model. , 2005, Heart rhythm.

[439] A. Kadish,et al. Effect of basic drive cycle length on the yield of ventricular tachycardia during programmed ventricular stimulation. , 1990, The American journal of cardiology.

[440] K. Sheth,et al. Electrocardiograms in Fabry's disease. , 1982, Journal of electrocardiology.

[441] K. McDonald,et al. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. , 2002, American heart journal.

[442] W. Kannel,et al. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[443] J. Kjekshus,et al. Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[444] R. Falk,et al. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. , 1997, Journal of the American College of Cardiology.

[445] A. Epstein,et al. Syncope and Inducible Ventricular Fibrillation in a Woman with Hemochromatosis , 1999, Journal of Interventional Cardiac Electrophysiology.

[446] H. Hecht. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes. , 2001, Circulation.

[447] R. Winkle,et al. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. , 1981, American Journal of Medicine.

[448] T. Suter,et al. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer. , 2004, Breast.

[449] C Antzelevitch,et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.

[450] Dan M Roden,et al. KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome , 2005, Circulation.

[451] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[452] J. Towbin,et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. , 2000, Circulation.

[453] M. Stanton,et al. Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients , 2001, Circulation.

[454] J. Langberg,et al. Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Coronary Artery Disease , 1993, Circulation.

[455] P. J. Phillip,et al. Recurrent seizures and syncope, ventricular arrhythmias with reversible prolonged Q-Tc interval in typhoid myocarditis. , 1987, Journal of the Indian Medical Association.

[456] P. E. Perlman,et al. Endocarditis. Changing trends in epidemiology, clinical and microbiologic spectrum. , 1993, Postgraduate medicine.

[457] B. Maron,et al. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.

[458] I. Swenne,et al. Heart risk associated with weight loss in anorexia nervosa and eating disorders: risk factors for QTc interval prolongation and dispersion , 1999, Acta paediatrica.

[459] B. Schnetzler,et al. Coronary spasm induced by capecitabine. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[460] Brahmajee K Nallamothu,et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[461] H. Wellens. Chapter-011 Ventricular Tachycardia: Diagnosis of Broad QRS Complex Tachycardia , 2007 .

[462] D. Zipes,et al. Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. , 1987, Journal of the American College of Cardiology.

[463] M Akhtar,et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. , 1989, Circulation.

[464] M. Ackerman,et al. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. , 2002, Mayo Clinic proceedings.

[465] T Heeren,et al. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. , 1984, American journal of epidemiology.

[466] W. Mckenna,et al. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[467] D. Roden. Mechanisms and management of proarrhythmia. , 1998, The American journal of cardiology.

[468] M. Packer. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. , 1992, Circulation.

[469] R. Virmani,et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. , 1998, Circulation.

[470] M. Burr,et al. Diet and reinfarction trial (DART): design, recruitment, and compliance. , 1989, European heart journal.

[471] Bortolo Martini,et al. Bidirectional tachycardia. A sustained form, not related to digitalis intoxication, in an adult without apparent cardiac disease. , 1988, Japanese heart journal.

[472] E. Prystowsky,et al. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?). , 2001, Circulation.

[473] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[474] A. S. Abraham,et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. , 1987, Archives of internal medicine.

[475] R. Virmani,et al. Sudden cardiac death. , 1987, Human pathology.

[476] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[477] S. Hohnloser,et al. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. , 1988, American heart journal.

[478] S. Priori,et al. A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene , 2005, Circulation research.

[479] A. Garson,et al. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias. , 1994, Journal of the American College of Cardiology.

[480] W. Aronow. Treatment of Ventricular Arrhythmias in Older Adults , 1995, Journal of the American Geriatrics Society.

[481] Tim Vaughn,et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. , 2003, Journal of the American College of Cardiology.

[482] A. B. Weisse,et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. , 1978, American heart journal.

[483] S. Roose,et al. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. , 1994, The Journal of clinical psychiatry.

[484] Giuseppe Curigliano,et al. Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[485] F. Aragona,et al. [Pheochromocytoma and catecholamine cardiomyopathy]. , 1992, Pathologica.

[486] G. Landes,et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[487] B. Gersh,et al. Risk factor profiles of patients with sudden cardiac death and death from other cardiac causes: a report from the Coronary Artery Surgery Study (CASS). , 1989, Journal of the American College of Cardiology.

[488] M. Josephson,et al. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. , 1984, The American journal of cardiology.

[489] S. Hohnloser,et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. , 1998, Circulation.

[490] R. Brooks,et al. Idiopathic Ventricular Tachycardia A REVIEW , 1988, Medicine.

[491] J. Boyd,et al. Effects of first‐dose doxorubicin on cardiac rhythm as evaluated by continuous 24‐hour monitoring , 1985, Cancer.

[492] A. Coats,et al. Variation in mode of sudden cardiac death in patients with dilated cardiomyopathy. , 1997, European heart journal.

[493] U. Goldbourt,et al. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. , 1990, The American journal of cardiology.

[494] W G Stevenson,et al. Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars. , 1995, Journal of the American College of Cardiology.

[495] P. Laippala,et al. Coronary artery disease modifies left ventricular remodelling due to heavy alcohol consumption. , 2001, Alcoholism, clinical and experimental research.

[496] B. Singh,et al. Liquid protein diets and torsade de pointes. , 1978, JAMA.

[497] R. Saumarez,et al. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. , 1994, Circulation.

[498] Martin Borggrefe,et al. Short QT Syndrome: A Familial Cause of Sudden Death , 2003, Circulation.

[499] J. Freed,et al. Magnesium deficiency and cardiac disorders. , 1975, The American journal of medicine.

[500] P. Savard,et al. Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. , 1991, American heart journal.

[501] Eric Fain,et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[502] J. Schulz-Menger,et al. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. , 2003, Magma.

[503] A J Camm,et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. , 1992, British heart journal.

[504] W. Stevenson,et al. Catheter Ablation in Patients With Multiple and Unstable Ventricular Tachycardias After Myocardial Infarction: Short Ablation Lines Guided by Reentry Circuit Isthmuses and Sinus Rhythm Mapping , 2001, Circulation.

[505] M. Link,et al. Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[506] E. Prystowsky,et al. Radiofrequency Catheter Ablation of Idiopathic Recurrent Ventricular Tachycardia with Right Bundle Branch Block, Left Axis Morphology , 1993, Pacing and clinical electrophysiology : PACE.

[507] R. Berg,et al. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. , 1992, Journal of the American College of Cardiology.

[508] W. Mckenna,et al. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. , 1984, The American journal of cardiology.

[509] R. Brugada,et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[510] L. Politano,et al. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. , 1997, International journal of cardiology.

[511] H Calkins,et al. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. , 1990, Circulation.

[512] G. Sutton,et al. Solitary tumour metastasis: a rare cause of right ventricular outflow tract obstruction and sudden death. , 1984, European heart journal.

[513] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[514] F. Camerini,et al. Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. , 1985, European heart journal.

[515] A. Colao. Are patients with acromegaly at high risk for dysrhythmias? , 2001, Clinical endocrinology.

[516] K. Kuwako,et al. Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system , 1992, British heart journal.

[517] R. Hauer,et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. , 1999, Circulation.

[518] C. Tracy,et al. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. , 1991, The American journal of cardiology.

[519] E. Epstein,et al. Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. , 1981, Circulation.

[520] I. Dal Conte,et al. [Cardiac complications in HIV infections]. , 1997, Giornale italiano di cardiologia.

[521] R. Lazzara,et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. , 1991, The New England journal of medicine.

[522] R. Prineas,et al. Sex differences in the evolution of the electrocardiographic QT interval with age. , 1992, The Canadian journal of cardiology.

[523] E. Green,et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[524] A. Firestone. Cardiac Risk of Psychotropic Drugs , 2002, The Australian and New Zealand journal of psychiatry.

[525] M. Davies,et al. Ecstasy induced acute myocardial infarction , 2001, Heart.

[526] R. Elston,et al. Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. , 2001, Circulation.

[527] J. Brugada,et al. Clinical and electrophysiologic characteristics of exercise-related idiopathic ventricular tachycardia. , 1991, The American journal of cardiology.

[528] J. Steinberg,et al. Does an open infarct-related artery after myocardial infarction improve electrical stability? , 2000, Progress in cardiovascular diseases.

[529] K. Murata,et al. Low‐dose dobutamine stress test for the evaluation of cardiac function using ultrafast computed tomography , 1993, Clinical Cardiology.

[530] F. Marchlinski,et al. 705-4 Idiopathic Right Ventricular Outflow Tract Tachycardia: Narrowing the Anatomic Location for Successful Ablation , 1995 .

[531] D. Faxon,et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[532] F. Chandler,et al. Lyme carditis. Electrophysiologic and histopathologic study. , 1986, The American journal of medicine.

[533] F. Marchlinski,et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. , 2000, Circulation.

[534] L. Magnius,et al. Acute myocarditis. Serologic diagnosis, clinical findings and follow-up. , 2009, Acta medica Scandinavica.

[535] S. Priori,et al. Clinical Implications for Affected Parents and Siblings of Probands With Long-QT Syndrome , 2001, Circulation.

[536] A. Camm,et al. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. , 1989, Circulation.

[537] R. Erbel,et al. Arrhythmia profile in acromegaly. , 1992, European heart journal.

[538] T. Sakata,et al. QT interval and QT dispersion before and after diet therapy in patients with simple obesity. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[539] B. Gersh,et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. , 1987, The American journal of cardiology.

[540] A. Kadish,et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. , 1998, Circulation.

[541] A. Heagerty,et al. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. , 1986, International journal of cardiology.

[542] V. Virdi,et al. Ventricular Tachycardia in Congenital Adrenal Hyperplasia , 2002, Anaesthesia and intensive care.

[543] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.

[544] Asad A. Rizvi,et al. Hypertrophic cardiomyopathy: Who plays and who sits , 2002, Current sports medicine reports.

[545] R. Lazzara. Antiarrhythmic drugs and torsade de pointes. , 1993, European heart journal.

[546] T. Imaizumi,et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[547] S. Chugh,et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. , 2005, JAMA.

[548] H. Greene. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. , 1993, The American journal of cardiology.

[549] G. Schmidt,et al. Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. , 2001, Journal of the American College of Cardiology.

[550] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[551] D. Tresch. Evaluation and management of cardiac arrhythmias in the elderly. , 2001, The Medical clinics of North America.

[552] M. Mckee,et al. Is the link between alcohol and cardiovascular death among young Russian men attributable to misclassification of acute alcohol intoxication? Evidence from the city of Izhevsk , 2002, Journal of epidemiology and community health.

[553] D. Barraclough,et al. Q fever presenting with paroxysmal ventricular tachycardia. , 1975, British medical journal.

[554] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[555] Diwakar Jain,et al. Emotional and Physical Precipitants of Ventricular Arrhythmia , 2002, Circulation.

[556] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[557] B. Wilske,et al. Persistent atrioventricular block in Lyme borreliosis , 1990, Klinische Wochenschrift.

[558] J. Muñoz,et al. Ventricular tachycardia in Duchenne's muscular dystrophy. , 1996, International journal of cardiology.

[559] B. Craig,et al. Ventricular Tachycardia Associated with Coxsackie B4 Virus Infection , 1990, Acta paediatrica Scandinavica.

[560] M. Gatzoulis,et al. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. , 1995, Circulation.

[561] S. Priori,et al. Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[562] M. Josephson,et al. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. , 1985, The American journal of cardiology.

[563] A. Camm,et al. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). , 1998, European heart journal.

[564] A. Greenspon,et al. The "holiday heart": electrophysiologic studies of alcohol effects in alcoholics. , 1983, Annals of internal medicine.

[565] J. Schwartz,et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. , 1999, Hypertension.

[566] H. Huikuri,et al. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. , 1989, Circulation.

[567] A. Keogh,et al. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. , 1990, The American journal of cardiology.

[568] R. Frank,et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: A 16-year experience , 2000, Current cardiology reports.

[569] S. Gorgulu,et al. A case of coronary spasm induced by 5-fluorouracil , 2002, Acta cardiologica.

[570] I. B. Kristensen,et al. Arrhythmogenic right ventricular dysplasia as a cause of sudden death. , 1997, The American journal of forensic medicine and pathology.

[571] Michael J Ackerman,et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[572] Paul J. Wang,et al. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). , 2003, The American journal of cardiology.

[573] Heikki V Huikuri,et al. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. , 2003, Circulation.

[574] E. Aliot,et al. Indications for implantable cardioverter defibrillator (ICD) therapy. , 2001 .

[575] V. Velebit,et al. Aggravation and Provocation of Ventricular Arrhythmias by Antiarrhythmic Drugs , 1982, Circulation.

[576] E. Boerwinkle,et al. Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases. , 1996, Human molecular genetics.

[577] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[578] L. Horowitz,et al. Use of intravenous verapamil for ventricular tachycardia. , 1984, The American journal of cardiology.

[579] J. Saul,et al. Preventing Sudden Death after Repair of Tetralogy of Fallot: , 1999, Journal of cardiovascular electrophysiology.

[580] M. Verani,et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. , 2000, Circulation.

[581] V. Preedy,et al. Effects of alcohol on the heart , 1997, Current opinion in critical care.

[582] David W. Smith,et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. , 1993, The New England journal of medicine.

[583] W. Stevenson,et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[584] S. Priori,et al. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. , 1998, The New England journal of medicine.

[585] F. Morady,et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[586] P. Vardas,et al. QT interval in cardiac amyloidosis , 1996, Clinical cardiology.

[587] R. Califf,et al. Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes , 2002, Circulation.

[588] T. Nakano,et al. Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[589] R. Pass,et al. Torsade de pointes in a child with acute rheumatic fever. , 2001, The Journal of pediatrics.

[590] P. Elliott,et al. Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy , 2002, Circulation.

[591] M A Hlatky,et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. , 1992, JAMA.

[592] P. Kokkinos,et al. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. , 1997, The American journal of cardiology.

[593] S. Priori,et al. CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.

[594] D. Echt,et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.

[595] S. Siu,et al. Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[596] W. Aronow,et al. Prevalence of arrhythmias detected by ambulatory electrocardiographic monitoring and of abnormal left ventricular ejection fraction in persons older than 62 years in a long-term health care facility. , 1987, The American journal of cardiology.

[597] R. Gillum,et al. Geographic variation in sudden coronary death. , 1990, American heart journal.

[598] C. Fisch,et al. OBSERVATIONS ON THE CARDIOVASCULAR INVOLVEMENT IN FRIEDREICH'S ATAXIA. , 1963, American heart journal.

[599] A. Nava,et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[600] M. Link,et al. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. , 2003, Circulation.

[601] A. Greenspon,et al. Provocation of ventricular tachycardia after consumption of alcohol. , 1979, The New England journal of medicine.

[602] H. Fleming. Cardiac sarcoidosis. , 1986, Clinics in dermatology.

[603] M. Josephson,et al. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. , 1991, The American journal of cardiology.

[604] F. Marchlinski,et al. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. , 1992, Journal of the American College of Cardiology.

[605] M Akhtar,et al. Ventricular Fibrillation and Polymorphic Ventricular Tachycardia with Critical Coronary Artery Stenosis: , 1994, Journal of cardiovascular electrophysiology.

[606] W. Kruyer,et al. Nonsustained ventricular tachycardia in 193 U.S. military aviators: long-term follow-up. , 2000, Aviation, space, and environmental medicine.

[607] T. Yamakado,et al. Prognosis of patients with hypertrophic cardiomyopathy in Japan. , 2002, Cardiac electrophysiology review.

[608] J. Langberg,et al. Radiofrequency Catheter Ablation of Accessory Atrioventricular Connections in 250 Patients: Abbreviated Therapeutic Approach to Wolff‐Parkinson‐White Syndrome , 1992, Circulation.

[609] S. Hohnloser,et al. Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator , 2004, Circulation.

[610] E. Heiman. Cardiac toxicity with thioridazine-tricyclic antidepressant combination. , 1977, The Journal of nervous and mental disease.

[611] J. Ruskin,et al. Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. , 2001, The American journal of cardiology.

[612] J. Coromilas,et al. Effect of -Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) , 2002 .

[613] A. Camm,et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[614] S. Viskin,et al. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. , 2001, Journal of the American College of Cardiology.

[615] P. Weston,et al. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The ‘dead in bed’ syndrome revisited , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[616] W. Stevenson,et al. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. , 1984, The American journal of cardiology.

[617] Calum A MacRae,et al. Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[618] S. Fisher,et al. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. , 1998, Journal of the American College of Cardiology.

[619] M. Brignole,et al. Diagnostic value of history in patients with syncope with or without heart disease. , 2001, Journal of the American College of Cardiology.

[620] R. Myerburg,et al. Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[621] State-specific mortality from sudden cardiac death--United States, 1999. , 2002, MMWR. Morbidity and mortality weekly report.

[622] S. Bharati,et al. Cardiac conduction system involvement in sudden death of obese young people. , 1995, American heart journal.

[623] E. Negri,et al. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base. , 2001, American heart journal.

[624] B. Maron,et al. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[625] J. Nordrehaug,et al. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. , 1985, Circulation.

[626] D. Blondheim,et al. Expert consensus document on management of cardiovascular diseases during pregnancy. , 2003, European heart journal.

[627] S. M. Solomon,et al. The refeeding syndrome: a review. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[628] S. Viskin,et al. Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome , 2004, Circulation.

[629] J. Rumberger,et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. , 1995, Circulation.

[630] B. Hedblad,et al. Ventricular arrhythmias during 24‐h ambulatory ECG recording: incidence, risk factors and prognosis in men with and without a history of cardiovascular disease , 1999, Journal of internal medicine.

[631] M. Zack,et al. Comparison of sudden and nonsudden coronary deaths in the United States. , 1996, Circulation.

[632] Karin V. Rhodes,et al. Racial Differences in the Incidence of Cardiac Arrest and Subsequent Survival , 1994 .

[633] A. Wilde,et al. Quinidine Induced Electrocardiographic Normalization in Two Patients with Brugada Syndrome , 2001, Pacing and clinical electrophysiology : PACE.

[634] W. Kannel,et al. SUDDEN CORONARY DEATH: THE FRAMINGHAM STUDY * , 1982, Annals of the New York Academy of Sciences.

[635] S. Priori,et al. A Newly Characterized SCN5A Mutation Underlying Brugada Syndrome Unmasked by Hyperthermia , 2003, Journal of cardiovascular electrophysiology.

[636] Jefferson Luiz Brum Marques,et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[637] M. Copass,et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. , 2002, JAMA.

[638] A. Agustí,et al. Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. , 1998, European heart journal.

[639] Marta J. Brooks,et al. The Refeeding Syndrome: An Approach to Understanding Its Complications and Preventing Its Occurrence , 1995, Pharmacotherapy.

[640] C. Mewis,et al. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. , 1999, Journal of the American College of Cardiology.

[641] T. Assimes,et al. Torsade de pointes with sotalol overdose treated successfully with lidocaine. , 1998, The Canadian journal of cardiology.

[642] S. Thomas,et al. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine. , 2003, British journal of clinical pharmacology.

[643] J. Jais,et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. , 1990, European heart journal.

[644] J. Guralnik,et al. Patterns of functional decline at the end of life. , 2003, JAMA.

[645] C. Caspersen,et al. Risk Factors for Sudden Coronary Death in the United States , 1997, Epidemiology.

[646] D. Wilber,et al. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. , 1990, Circulation.

[647] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[648] A. Marian,et al. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. , 1995, European heart journal.

[649] J. Herlitz,et al. Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden. , 2000, Resuscitation.

[650] F. Pelliccia,et al. Predictors of sudden death in idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[651] N. Hardin,et al. Iatrogenic cardiac herniation: post mortem case. , 1984, The Journal of trauma.

[652] S. Saksena,et al. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. , 1995, The American journal of cardiology.

[653] D. Wyse,et al. Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.

[654] M. Ueda,et al. Development and Validation of an ECG Algorithm for Identifying the Optimal Ablation Site for Idiopathic Ventricular Outflow Tract Tachycardia , 2003, Journal of cardiovascular electrophysiology.

[655] Richard P. Lewis,et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardio , 1997, Circulation.

[656] R. Kyle,et al. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. , 1995, Seminars in hematology.

[657] R. Friedman,et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. , 2003, Journal of cardiac failure.

[658] M. de Lorgeril,et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.

[659] C. Autore,et al. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy , 2007, Current treatment options in cardiovascular medicine.

[660] D. Schocken,et al. Weight loss and the heart. Effects of anorexia nervosa and starvation. , 1989, Archives of internal medicine.

[661] E. Gilpin,et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. , 1988, The American journal of cardiology.

[662] J. Leor,et al. Sudden cardiac death triggered by an earthquake. , 1996, The New England journal of medicine.

[663] W. Aronow,et al. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias. , 1990, The American journal of cardiology.

[664] A H Glassman,et al. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[665] J. Schläpfer,et al. Ten‐Years Follow‐Up of 20 Patients with Idiopathic Ventricular Tachycardia , 1990, Pacing and clinical electrophysiology : PACE.

[666] H. Watkins,et al. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.

[667] A. Singh,et al. Refractory Ventricular Tachycardia Following Aortic Valve Replacement Complicated by Unsuspected Pheochromocytoma , 1993, The Thoracic and cardiovascular surgeon.

[668] E. Ferrari,et al. [Cardiotoxicity associated with trastuzumab (herceptin). An undesired effect leads towards a model of cardiac insufficiency]. , 2004, Archives des maladies du coeur et des vaisseaux.

[669] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[670] D. Zipes,et al. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. , 1979, The American journal of cardiology.

[671] I. Gessner,et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. , 2000, Journal of the American College of Cardiology.

[672] J. Hoffman,et al. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. , 1993, The American journal of emergency medicine.

[673] E. Warman,et al. Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator , 2001, Circulation.

[674] J. Mitchell,et al. Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities. , 1994, Medicine and science in sports and exercise.

[675] M. Biehl,et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. , 1997, Journal of the American College of Cardiology.

[676] L. Kunkel,et al. Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[677] V. Athyros,et al. Effect of Chronic Quinapril Administration on Heart Rate Variability in Patients With Diabetic Autonomic Neuropathy , 1997, Diabetes Care.

[678] B. Gersh,et al. Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure. , 1997, The American journal of cardiology.

[679] A. Nogami. Idiopathic left ventricular tachycardia: assessment and treatment. , 2002, Cardiac electrophysiology review.

[680] J. Manson,et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.

[681] P. Kowey,et al. Intravenous amiodarone. , 1997, Journal of the American College of Cardiology.

[682] G. de Martino,et al. MYOTONIC DYSTROPHY AND THE HEART , 2002, Heart.

[683] R. Virmani,et al. Sudden death in right ventricular dysplasia with minimal gross abnormalities. , 1999, Journal of forensic sciences.

[684] R. Canby,et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[685] L. Epstein,et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. , 1994, Journal of the American College of Cardiology.

[686] F. Marcus,et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Review , 1995, Pacing and clinical electrophysiology : PACE.

[687] N. Kanemoto. Natural history of pulmonary hemodynamics in primary pulmonary hypertension. , 1987, American heart journal.

[688] J. Ruskin,et al. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. , 1990, Journal of the American College of Cardiology.

[689] M. Josephson,et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[690] R. A. Cohen,et al. Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications , 2003, Heart.

[691] J. Towbin,et al. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[692] A. Ross,et al. Acute arrhythmogenicity of doxorubicin administration , 1987, Cancer.

[693] H. Greene,et al. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. , 1987, Annals of internal medicine.

[694] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[695] A. Garson. Ventricular arrhythmias after repair of congenital heart disease: Who needs treatment? , 1991, Cardiology in the Young.

[696] U. Bergman,et al. Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries. , 2002, British journal of clinical pharmacology.

[697] G. Berry,et al. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[698] C. Autore,et al. Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.

[699] A. Moss,et al. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. , 1997, Journal of the American College of Cardiology.

[700] D. Bonaduce,et al. Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide , 2003, Clinical endocrinology.

[701] A. Gramolini,et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death , 2003, Nature.

[702] E. Rosenthal,et al. Prolongation of the QT interval and the sudden infant death syndrome. , 1998, The New England journal of medicine.

[703] N. Estes,et al. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. , 1992, American Journal of Cardiology.

[704] J. Kupersmith,et al. Myotonic dystrophy: ambulatory electrocardiogram, electrophysiologic study, and echocardiographic evaluation. , 1987, American heart journal.

[705] F. Messerli,et al. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. , 1987, Archives of internal medicine.

[706] F. Bu'Lock,et al. Early identification of anthracycline cardiomyopathy: possibilities and implications. , 1996, Archives of disease in childhood.

[707] R. Cappato,et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[708] J. Mcanulty,et al. Determinants of induced sustained arrhythmias in survivors of out-of-hospital ventricular fibrillation. , 1987, Circulation.

[709] L. Cobb,et al. Smoking as a risk factor for recurrence of sudden cardiac arrest. , 1986, The New England journal of medicine.

[710] K. Lee,et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. , 2000, The New England journal of medicine.

[711] D K McKenas,et al. Use of automated external defibrillators by a U.S. airline. , 2000, The New England journal of medicine.

[712] J. Kastor,et al. Coronary-artery spasm immediately after myocardial revascularization: recognition and management. , 1981, The New England journal of medicine.

[713] L. P. Tham,et al. Paediatric out-of-hospital cardiac arrests: epidemiology and outcome. , 2005, Singapore medical journal.

[714] H. Kennedy,et al. Beta-blocker therapy in the cardiac arrhythmia suppression trial , 1994 .

[715] H. Wellens,et al. Electrical Stimulation of the Heart in Patients with Ventricular Tachycardia , 1972, Circulation.

[716] P. C. Viswanathan,et al. Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes , 2002, Circulation.

[717] W. Pedersen,et al. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. , 1989, The American journal of cardiology.

[718] R. Passman,et al. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. , 2002, The American journal of cardiology.

[719] A. Jaffe,et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. , 2000, American heart journal.

[720] K. Bailey,et al. A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[721] D. Roden,et al. Suppression of Bidirectional Ventricular Tachycardia and Unmasking of Prolonged QT interval with Verapamil in Andersen's Syndrome , 2004, Journal of cardiovascular electrophysiology.

[722] J. Ruskin,et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. , 1994, Circulation.

[723] Harold L. Kennedy,et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. , 1985, The New England journal of medicine.

[724] J. Hirshfeld,et al. Perioperative coronary arterial spasm: long-term follow-up. , 1982, The American journal of cardiology.

[725] L. Cooper,et al. Giant Cell Myocarditis: Diagnosis and Treatment , 2000, Herz.

[726] M. Davies,et al. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy , 1999, Heart.

[727] C. Nienaber,et al. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. , 1990, Journal of the American College of Cardiology.

[728] T. Meinertz,et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. , 1985, The American journal of cardiology.

[729] N. Freemantle,et al. Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.

[730] E. Nagel,et al. Prehospital ventricular defibrillation. Prognosis and follow-up course. , 1974, The New England journal of medicine.

[731] J. Brugada,et al. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. , 2001, Journal of the American College of Cardiology.

[732] F. Koberle. [Chagas' heart disease]. , 1958, Hospital.

[733] R Anilkumar,et al. Radiofrequency ablation for post infarction ventricular tachycardia. Report of a single centre experience of 112 cases. , 2002, European heart journal.

[734] W. Guntheroth. Long QT Syndrome in Children , 1993, Circulation.

[735] Bramahn . Singh. Amiodarone compared with lidocaine for shock-resistant ventricular fibrillation , 2002, Current cardiology reports.

[736] G. Danieli,et al. Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43. , 2000, The American journal of cardiology.

[737] Wen-Chung Yu,et al. Ventricular Tachycardia in a Patient with Primary Hyperparathyroidism , 2000, Pacing and clinical electrophysiology : PACE.

[738] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[739] J. Hollifield. Magnesium depletion, diuretics, and arrhythmias. , 1987, American Journal of Medicine.

[740] G. Danieli,et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[741] Peter J. Schwartz,et al. Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.

[742] Philip Sager,et al. Identification of Reentry Circuit Sites During Catheter Mapping and Radiofrequency Ablation of Ventricular Tachycardia Late After Myocardial Infarction , 1993, Circulation.

[743] W. Mckenna,et al. Good prognosis for dilated cardiomyopathy without severe heart failure or arrhythmia. , 1990, The Quarterly journal of medicine.

[744] M Freedman,et al. Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction , 2001, Circulation.

[745] A. Hallstrom,et al. Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. , 1993, The New England journal of medicine.

[746] B. McCrindle,et al. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. , 1996, American heart journal.

[747] G. Aurigemma,et al. Ventricular arrhythmias in adult aortic stenosis: prevalence, mechanisms, and clinical relevance. , 1998, Chest.

[748] G. Divine,et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. , 1990, The American journal of cardiology.

[749] G. Kay,et al. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. , 2004, Journal of the American College of Cardiology.

[750] C. Tracy,et al. Radiofrequency Endocardial Catheter Ablation of Accessory Atrioventricular Pathway Atrial Insertion Sites , 1993, Circulation.

[751] D. Tester,et al. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. , 1999, Mayo Clinic proceedings.

[752] W. Dassen,et al. Comprehensive Clinical Electrophysiologic Studies in the Investigation of Documented or Suspected Tachyeardias: Time, Staff, Problems and Costs , 1980, Circulation.

[753] K. Jamrozik,et al. Risk factors for sudden unexpected cardiac death in Tasmanian men. , 1997, Australian and New Zealand journal of medicine.

[754] C. Oakley,et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[755] A. Anand. Fluorouracil Cardiotoxicity , 1994, The Annals of pharmacotherapy.

[756] R. Salonen,et al. Triptans and coronary spasm. , 2000, Clinical pharmacology and therapeutics.

[757] W. Stevenson,et al. Sudden Death Prevention in Patients With Advanced Ventricular Dysfunction , 1993, Circulation.

[758] K M Kessler,et al. Frequency of sudden cardiac death and profiles of risk. , 1997, The American journal of cardiology.

[759] R. Carney,et al. Effects of mental stress in patients with coronary artery disease: evidence and clinical implications. , 2000, JAMA.

[760] F. Morady,et al. Brugada Syndrome Mimicked by Tricyclic Antidepressant Overdose , 2001, Journal of cardiovascular electrophysiology.

[761] L. Thierfelder,et al. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. , 1999, International journal of cardiology.

[762] A. Moss,et al. Factors associated with ventricular inducibility in the MADIT-II study population. , 2003, The American journal of cardiology.

[763] V. Stone,et al. Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[764] S. Ernst,et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. , 2002, Journal of the American College of Cardiology.

[765] H. Wellens,et al. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. , 1974, The New England journal of medicine.

[766] W. Stevenson,et al. Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. , 1990, Journal of the American College of Cardiology.

[767] R. Bain. Accidental digitalis poisoning due to drinking herbal tea. , 1985, British medical journal.

[768] A. Morice,et al. Collapse with a streptococcal infection , 1999, The Lancet.

[769] D. Zipes,et al. Thoracic Spinal Cord Stimulation Reduces the Risk of Ischemic Ventricular Arrhythmias in a Postinfarction Heart Failure Canine Model , 2005, Circulation.

[770] M. Schalij,et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. , 2006, Heart rhythm.

[771] M. Josephson,et al. Resetting of ventricular tachycardia: implications for localizing the area of slow conduction. , 1988, Journal of the American College of Cardiology.

[772] Paul Schoenhagen,et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. , 2005, The New England journal of medicine.

[773] W. Frishman,et al. Infectious mononucleosis and fatal myocarditis. , 1977, Chest.

[774] F. Crawford,et al. New approaches to treatment of incessant ventricular tachycardia in the very young. , 1990, Journal of the American College of Cardiology.

[775] J. Vandenbroucke,et al. QT Interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population , 1991, Circulation.

[776] P. Brugada,et al. Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia. , 1989, Journal of the American College of Cardiology.

[777] B. Strauer,et al. Detection of enteroviral RNA (poliovirus types 1 and 3) in endomyocardial biopsies from patients with ventricular tachycardia and survivors of sudden cardiac death. , 2002, Scandinavian journal of infectious diseases.

[778] W. Helbing,et al. Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[779] C. Tai,et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. , 1995, The American journal of cardiology.

[780] M. Malik,et al. Social and psychosocial influences on sudden cardiac death, ventricular arrhythmia and cardiac autonomic function. , 2001, European heart journal.

[781] A. Moss,et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. , 1998, Circulation.

[782] G. Breithardt,et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[783] R. Friedman,et al. Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults. , 1994, Journal of the American College of Cardiology.

[784] R. DeSilva. CENTRAL NERVOUS SYSTEM RISK FACTORS FOR SUDDEN CARDIAC DEATH * , 1982, Journal of the South Carolina Medical Association.

[785] David A. Leon,et al. Alcohol and cardiovascular mortality in Moscow; new evidence of a causal association. , 1998, Journal of epidemiology and community health.

[786] D. Burkhoff,et al. &bgr;-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure , 2003, Circulation.

[787] M. Frenneaux,et al. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.

[788] J. T. Bricker,et al. Sudden death and tetralogy of Fallot. Risks, markers, and causes. , 1995, Circulation.

[789] S. Wannamethee,et al. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease , 2000, Heart.

[790] M. Josephson,et al. Evaluation of patients with palpitations. , 1998, The New England journal of medicine.

[791] K. Nademanee,et al. Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. , 2000, Circulation.

[792] A. Maggioni,et al. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. , 1989, The American journal of cardiology.

[793] S. Peters. Left ventricular impairment in arrhythmogenic right ventricular dysplasia: what we can learn from angiography. , 1995, Cardiology.

[794] S. Siu,et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.

[795] S. Epstein,et al. Prognostic Determinants in Hypertrophic Cardiomyopathy: Prospective Evaluation of a Therapeutic Strategy Based on Clinical, Holter, Hemodynamic, and Electrophysiological Findings , 1992, Circulation.

[796] Rose Anne Kenny,et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. , 2005, European heart journal.

[797] S. Priori,et al. Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[798] E. Aliot,et al. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. , 2001, European heart journal.

[799] P. Kowey,et al. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation. , 1999, The American journal of cardiology.

[800] R O Bonow,et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. , 1989, Circulation.

[801] A. V. van Ginneken,et al. Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome , 2004, Circulation.

[802] G. Guiraudon,et al. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. , 1983, Circulation.

[803] S. Winters,et al. Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy. , 1994, Progress in cardiovascular diseases.

[804] T. Nakata,et al. Prognosis of hypertrophic cardiomyopathy: Assessment by123I-BMIPP (β-methyl-p-(123I)iodophenyI pentadecanoic acid) myocardial single photon emission computed tomography , 1996, Annals of nuclear medicine.

[805] E. Lichstein,et al. Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient. , 1973, The American journal of cardiology.

[806] M. Kodama,et al. Recovery from complete atrioventricular block caused by idiopathic giant cell myocarditis after corticosteroid therapy. , 1998, Japanese circulation journal.

[807] L. Cooper,et al. Idiopathic giant cell myocarditis , 2001, Current treatment options in cardiovascular medicine.

[808] G. Breithardt,et al. Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome , 2005, Circulation.

[809] R. Virmani,et al. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. , 1995, Circulation.

[810] E. Prystowsky,et al. Use of the signal-averaged electrocardiogram for predicting inducible ventricular tachycardia in patients with unexplained syncope: relation to clinical variables in a multivariate analysis. , 1994, Journal of the American College of Cardiology.

[811] J. Mason,et al. Electrophysiologic testing in patients with the long QT syndrome. , 1985, Circulation.

[812] R. Hiss,et al. Electrocardiographic Findings in 122,043 Individuals , 1962, Circulation.

[813] S. Hohnloser,et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. , 2003, Journal of the American College of Cardiology.

[814] G. Breithardt,et al. Physician-Induced Torsade de Pointes—Therapeutic Implications , 2002, Cardiovascular Drugs and Therapy.

[815] E. Prystowsky,et al. Management of ventricular arrhythmias: detection, drugs, and devices. , 1999, JAMA.

[816] P. Dorian,et al. Cesium-induced torsades de pointes. , 2002, The New England journal of medicine.

[817] E. Antman,et al. Declining Incidence of Ventricular Fibrillation in Myocardial Infarction: Implications for the Prophylactic Use of Lidocaine , 1992, Circulation.

[818] P. Carli,et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. , 1999, The New England journal of medicine.

[819] M. Drazner,et al. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[820] E J Orav,et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.

[821] E. Berbari,et al. Late Potentials Are Unaffected by Radiofrequency Catheter Ablation in Patients with Ventricular Tachycardia , 1994, Pacing and clinical electrophysiology : PACE.

[822] J. Blumenthal,et al. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.

[823] J. Moller,et al. Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease. , 1977, American heart journal.

[824] K. Mcdonough,et al. The Effect of Acute Ethanol Exposure on the Chronotropic and Inotropic Function of the Rat Right Atrium , 2000, The Journal of pharmacy and pharmacology.

[825] G. Corrado,et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. , 2002, The American journal of cardiology.

[826] Norbertus C. Robben,et al. The syndrome of 5‐fluorouracil cardiotoxicity. An elusive cardiopathy , 1993, Cancer.

[827] M. Copass,et al. Community-based interventions for sudden cardiac death. Impact, limitations, and changes. , 1992, Circulation.

[828] M. Josephson,et al. Hybrid Pharmacologic and Ablative Therapy: A Novel and Effective Approach for the Management of Atrial Fibrillation , 1998, Journal of cardiovascular electrophysiology.

[829] P. Rizzon,et al. Programmed stimulation in patients with minor forms of right ventricular dysplasia. , 1989, European heart journal.

[830] T. Lundman,et al. Unexpected death in patients suffering from eating disorders , 1986, Acta psychiatrica Scandinavica.

[831] M. Lenk,et al. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography. , 1998, The Turkish journal of pediatrics.

[832] P. Brugada,et al. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. , 1989, Circulation.

[833] J. Mason,et al. Sudden death in idiopathic dilated cardiomyopathy. , 1987, Annals of internal medicine.

[834] U. Sigwart,et al. New concepts in hypertrophic cardiomyopathies, part I. , 2001, Circulation.

[835] K. Dickstein,et al. [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[836] D. Ward,et al. The QT and QS2 intervals in patients with mitral leaflet prolapse. , 1987, American heart journal.

[837] W. Kamps,et al. Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: a longitudinal study. , 2002, Medical and pediatric oncology.

[838] Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 7: algorithm approach to ACLS emergencies: section 7A: principles and practice of ACLS. The American Heart Association in collaboration with the International Li , 2000, Circulation.

[839] A. Garson,et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. , 1990, The American journal of cardiology.

[840] H. Wellens,et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. , 1995, The American journal of cardiology.

[841] M. Fishbein,et al. Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis. , 2003, Texas Heart Institute journal.

[842] A. García-Alberola,et al. Brugada‐Like Electrocardiographic Pattern Induced by Fever , 2002, Pacing and clinical electrophysiology : PACE.

[843] M. Silka,et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. , 1998, Journal of the American College of Cardiology.

[844] D. Roden,et al. Normalization of acquired QT prolongation in humans by intravenous potassium. , 1997, Circulation.

[845] D. Grana,et al. Cardiac involvement in acquired immunodeficiency syndrome—a review to push action , 1998, Clinical cardiology.

[846] J. Bénézet,et al. Fever-induced ST-segment elevation and T-wave alternans in a patient with Brugada syndrome. , 2003, Resuscitation.

[847] B M Psaty,et al. Family history as a risk factor for primary cardiac arrest. , 1998, Circulation.

[848] G. Breithardt,et al. Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients , 2004, Circulation.

[849] R. Gillum. Sudden cardiac death in Hispanic Americans and African Americans. , 1997, American journal of public health.

[850] P. Mcnair,et al. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double‐blind placebo‐controlled study , 1987, Clinical cardiology.

[851] D. Rovner,et al. Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[852] J F Leclercq,et al. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[853] E. Antman,et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[854] M. Crawford,et al. Results of resting and ambulatory electrocardiograms in patients with hypothyroidism and after return to euthyroid status. , 1999, Heart disease.

[855] Perry Elliott,et al. Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy. , 2002, Cardiac electrophysiology review.

[856] S. A. Jaoudé,et al. T Wave Pacing Inducing Electrical Storm and Multiple Shocks in an ICD-Recipient: A Novel Complication of the Automatic Gain Control Function , 2003, Journal of Interventional Cardiac Electrophysiology.

[857] T. Butler,et al. QT prolongation and sudden cardiac death in patients with alcoholic liver disease , 1993, The Lancet.

[858] F. Cappuccio,et al. Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia , 2002, Science.

[859] B. McManus,et al. Fatal dissection of the pulmonary trunk. An obscure consequence of chronic pulmonary hypertension. , 1988, The American journal of cardiovascular pathology.

[860] E. Friedmann,et al. Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): a reexamination. , 1997, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[861] L. Pires,et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. , 2000, The American journal of cardiology.

[862] M. Enriquez-Sarano,et al. Sudden death in mitral regurgitation due to flail leaflet. , 1999, Journal of the American College of Cardiology.

[863] J. Fleg,et al. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. , 1983, Chest.

[864] R. Califf,et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. , 1998, Circulation.

[865] S. Deshpande,et al. Bundle Branch Reentrant Ventricular Tachycardia: , 1993, Journal of cardiovascular electrophysiology.

[866] A. Moss. MADIT-II and its implications. , 2003, European heart journal.

[867] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[868] V. Mathew,et al. Atrioventricular sequential pacing in cardiac amyloidosis: An acute doppler echocardiographic and catheterization hemodynamic study , 1997, Clinical cardiology.

[869] B. Maron,et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. , 1981, The American journal of cardiology.

[870] W. Stevenson,et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[871] M. Josephson,et al. Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial , 2002, Circulation.

[872] C. Tondo,et al. Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia , 2002, Heart.

[873] B. Pitt,et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[874] S. Hohnloser,et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. , 1991, American heart journal.

[875] A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. , 1983, JAMA.

[876] S. Viskin,et al. Long QT syndrome caused by noncardiac drugs. , 2003, Progress in cardiovascular diseases.

[877] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[878] R. Stout,et al. Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[879] M Gent,et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[880] H. Huikuri,et al. Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.

[881] J. Riggs. The periodic paralyses. , 1988, Neurologic clinics.

[882] B. Maron. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator. , 2000, European heart journal.

[883] J. Karjalainen,et al. The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy. , 1995, European heart journal.

[884] C. Oster,et al. Prolonged Recurrence of Pentamidine-Induced Torsades de Pointes , 1992, The Annals of pharmacotherapy.

[885] R. Hariman,et al. Long-term follow-up in patients with incessant ventricular tachycardia. , 1990, The American journal of cardiology.

[886] J. Mason,et al. Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. , 1988, The American journal of cardiology.

[887] W. Kannel,et al. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.

[888] W. Kapoor,et al. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. , 1988, The American journal of cardiology.

[889] E. Mylonakis,et al. Infective endocarditis in adults. , 2001, The New England journal of medicine.

[890] A. Camm,et al. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). , 2000, Journal of the American College of Cardiology.

[891] G. Nesher,et al. Recurrent ventricular tachycardia in hypothyroidism--report of a case and review of the literature. , 1988, The Cardiology.

[892] G. Williams,et al. Results of 24 hour ambulatory monitoring of electrocardiogram in 131 healthy boys aged 10 to 13 years. , 1980, British heart journal.

[893] M. Samuels. Neurally induced cardiac damage. Definition of the problem. , 1993, Neurologic clinics.

[894] W. Grimm,et al. Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy , 2004, Herz.

[895] A. Camm,et al. Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds , 1983, Pacing and clinical electrophysiology : PACE.

[896] H. Wellens,et al. Age at onset and gender of patients with different types of supraventricular tachycardias. , 1992, The American journal of cardiology.

[897] W. Mckenna,et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. , 1981, The American journal of cardiology.

[898] Takanori Ikeda,et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. , 2002, The American journal of cardiology.

[899] J. Videbaek,et al. Lyme carditis: a clinical presentation and long time follow-up. , 1997, Scandinavian journal of infectious diseases.

[900] M. Rosenqvist,et al. Holter Documented Sudden Death in a Patient with an Implanted Defibrillator , 1992, Pacing and clinical electrophysiology : PACE.

[901] J. Triedman,et al. Benefits and Potential Risks of Atrial Antitachycardia Pacing After Repair of Congenital Heart Disease , 1995, Pacing and clinical electrophysiology : PACE.

[902] N. Rehnqvist,et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. , 1985, Journal of the American College of Cardiology.

[903] R. Gow. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2001, Circulation.

[904] T. Graboys,et al. Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. , 1984, Circulation.

[905] M. Daemen,et al. Identification of Genes Potentially Involved in Rupture of Human Atherosclerotic Plaques , 2001, Circulation research.

[906] J. Langberg,et al. Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: results and long-term follow-up. , 1991, Journal of the American College of Cardiology.

[907] M. Munclinger,et al. Follow-up of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[908] R. Collins,et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.

[909] C. Rapezzi,et al. [Cardiac involvement in HIV infection: a prospective, multicenter clinical and echocardiographic study]. , 1990, Cardiologia.

[910] B. Wilkoff,et al. Relationship Between Rehospitalization and Future Death in Patients Treated for Potentially Lethal Arrhythmia , 2001, Journal of cardiovascular electrophysiology.

[911] W. McKenna,et al. The natural history of hypertrophic cardiomyopathy. , 1981, Cardiovascular clinics.

[912] M. Josephson,et al. Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake , 2005, Circulation.

[913] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[914] F. Morady,et al. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. , 2003, Journal of the American College of Cardiology.

[915] J. Perloff,et al. Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy). Report of 2 cases and review of 17 published cases. , 1979, The American journal of cardiology.

[916] J J Bailey,et al. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. , 2001, Journal of the American College of Cardiology.

[917] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[918] Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? , 2002, International journal of clinical practice. Supplement.

[919] L. Mestroni,et al. Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. , 1987, American heart journal.

[920] J. Noonan,et al. Late Echocardiographic Findings Following Childhood Chemotherapy with Normal Serial Cardiac Monitoring , 1996, Journal of pediatric hematology/oncology.

[921] R. Winkle,et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. , 1996, Journal of the American College of Cardiology.

[922] S. Peters,et al. Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia. , 1995, European heart journal.

[923] L. Kuller,et al. Epidemiological Study of Sudden and Unexpected Deaths due to Arteriosclerotic Heart Disease , 1966, Circulation.

[924] J. Cigarroa,et al. Late revascularization reduces mortality in survivors of myocardial infarction. , 1999, Cardiology in review.

[925] E. Sacanella,et al. Diastolic function impairment in alcoholics. , 2000, Alcoholism: Clinical and Experimental Research.

[926] Douglas S Lee,et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[927] J. Devriendt,et al. Legionellosis and "torsades de pointes". , 1990, Acta cardiologica.

[928] B. Lerman,et al. Electrophysiological Evaluation of Sustained Ventricular Tachyarrhythmias in Idiopathic Dilated Cardiomyopathy , 1988, Pacing and clinical electrophysiology : PACE.

[929] C. Furlanello,et al. Cardiac Arrest and Sudden Death in Competitive Athletes with Arrhythmogenic Right Ventricular Dysplasia , 1998, Pacing and clinical electrophysiology : PACE.

[930] R. Krittayaphong,et al. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. , 2002, American heart journal.

[931] T. Miyazaki,et al. Repetitive Monomorphic Ventricular Tachycardia of Left Coronary Cusp Origin , 1999, Pacing and clinical electrophysiology : PACE.

[932] A. Wilde,et al. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. , 1999, Circulation.

[933] D. Webb,et al. Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy , 1991, Circulation.

[934] R. Hauer,et al. Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a "focal" activation pattern. , 1991, Journal of the American College of Cardiology.

[935] M. Keating,et al. A new form of long QT syndrome associated with syndactyly. , 1995, Journal of the American College of Cardiology.

[936] P. Krasilnikoff,et al. INTERMITTENT MUSCULAR WEAKNESS, EXTRASYSTOLES, AND MULTIPLE DEVELOPMENTAL ANOMALIES , 1971, Acta paediatrica Scandinavica.

[937] A. Moss,et al. The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[938] F. Morady,et al. A prospective comparison of triple extrastimuli and left ventricular stimulation in studies of ventricular tachycardia induction. , 1984, Circulation.

[939] R. Mulleneers,et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. , 1996, The American journal of cardiology.

[940] B. Massie,et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. , 2000, Circulation.

[941] E. Fain,et al. Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial , 2005 .

[942] R. D'Agostino,et al. Sudden death risk in overt coronary heart disease: the Framingham Study. , 1987, American heart journal.

[943] W. Kannel,et al. Sudden death: lessons from subsets in population studies. , 1985, Journal of the American College of Cardiology.

[944] V. Wenzel,et al. Arginine vasopressin during cardiopulmonary resuscitation: laboratory evidence, clinical experience and recommendations, and a view to the future. , 2002, Critical care medicine.

[945] H. Dickhuth,et al. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility. , 2004, International Journal of Sports Medicine.

[946] S. Siu,et al. Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease , 2001, Circulation.

[947] Sandeep Vijan,et al. Public use of automated external defibrillators. , 2003, The New England journal of medicine.

[948] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[949] L. Horowitz,et al. Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function. , 1985, Journal of the American College of Cardiology.

[950] R. Hauer,et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management , 2022 .

[951] P. D. Chapman,et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. , 1991, The American journal of medicine.

[952] V. Fuster,et al. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. , 1998, Circulation.

[953] J. Kisslo,et al. The clinical utility of transesophageal echocardiography in patients with left-sided infective endocarditis. , 1995, American journal of cardiac imaging.

[954] J P Miller,et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[955] L. Hinkle,et al. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. , 1969, The American journal of cardiology.

[956] V. Essebag,et al. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness. , 2003, Cardiac electrophysiology review.

[957] M. Landray,et al. The cardioprotective role of β‐blockers in patients with diabetes mellitus , 2002, Journal of clinical pharmacy and therapeutics.

[958] D. Atkins,et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[959] D. Roden,et al. Acute electrophysiologic effects of sodium administration in dogs treated with O-desmethyl encainide. , 1989, Circulation.

[960] P. Ridker,et al. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[961] L. Kuller,et al. AN EPIDEMIOLOGICAL STUDY OF SUDDEN AND UNEXPECTED DEATHS IN ADULTS , 1967, Medicine.

[962] J. Fisler. Cardiac effects of starvation and semistarvation diets: safety and mechanisms of action. , 1992, The American journal of clinical nutrition.

[963] G. Berry,et al. Survival Outcomes of Patients with Giant Cell Myocarditis Bridged by Ventricular Assist Devices , 2000, ASAIO journal.

[964] G. Lip,et al. Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia. , 2003, ACP journal club.

[965] A. Camm,et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[966] C. Hengstenberg,et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). , 1995, European heart journal.

[967] H. Calkins,et al. NASPE Expert Consensus Conference: Radiofrequency Catheter Ablation in Children with and without Congenital Heart Disease. Report of the Writing Committee , 2002, Pacing and clinical electrophysiology : PACE.

[968] M. Flynn,et al. Cardiovascular complications of weight reduction diets. , 2001, The American journal of the medical sciences.

[969] O. C. Ward. A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964, Journal of the Irish Medical Association.

[970] S. Solomon,et al. Ventricular Arrhythmias in Trials of Thrombolytic Therapy for Acute Myocardial Infarction A Meta‐Analysis , 1993, Circulation.

[971] M. Janse,et al. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[972] J. Goldberg,et al. Repeated 1 hour electrocardiographic monitoring of survivors of myocardial infarction at 6 month intervals: arrhythmia detection and relation to prognosis. , 1981, The American journal of cardiology.

[973] J. Cook,et al. Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. The CABG Patch Trial. , 1998, The American journal of cardiology.

[974] M. Keating,et al. MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[975] K. Bailey,et al. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. , 1995, Circulation.

[976] M. Lehmann,et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.

[977] T. Paul,et al. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. , 1999, Journal of the American College of Cardiology.

[978] R. Bebb,et al. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. , 1999, The Canadian journal of cardiology.

[979] K. Shakir,et al. Pheochromocytoma associated ventricular tachycardia blocked with atenolol , 1990, Journal of endocrinological investigation.

[980] A. Jervell,et al. CONGENITAL DEAF‐MUTISM, FUNCTIONAL HEART DISEASE WITH PROLONGATION OF THE Q‐T INTERVAL, AND SUDDEN DEATH , 1999, American heart journal.

[981] J. Bigger,et al. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. , 2000, Journal of the American College of Cardiology.

[982] David O'Donnell,et al. Radiofrequency Ablation for Post Infarction Ventricular Tachycardia , 2004, Indian pacing and electrophysiology journal.

[983] H. Inoue,et al. Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. , 1999, The American journal of cardiology.

[984] Javid A. Malik,et al. Transient complete heart block complicating acute rheumatic fever. , 2002, Indian heart journal.

[985] P. J. Wang,et al. Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. , 2001, JAMA.

[986] J. A. Painter,et al. The electrocardiogram in morbid obesity. , 2000, The American journal of cardiology.

[987] G. V. Van Hare,et al. The Long QT Syndrome in Children An International Study of 287 Patients , 1993, Circulation.

[988] G. Palladini,et al. Holter Monitoring in AL Amyloidosis: Prognostic Implications , 2001, Pacing and clinical electrophysiology : PACE.

[989] M. Sanguinetti,et al. Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.

[990] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[991] A. Angelini,et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[992] K. Brown,et al. Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia , 2001, Circulation.

[993] M. Bullard,et al. Anticholinergic overdose induced torsade de pointes successfully treated with verapamil. , 1996, Japanese heart journal.

[994] M. Herzum,et al. Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[995] K. P. Carney,et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[996] S. Priori,et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. , 2005, JAMA.

[997] J. Daubert,et al. Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). , 2003, American Journal of Cardiology.

[998] H. White,et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. , 2005, Journal of the American College of Cardiology.

[999] Lance B Becker,et al. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. , 2002, JAMA.

[1000] R. Millar,et al. A prospective study of electrical cardioversion for sustained tachycardias by emergency unit personnel. , 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[1001] A Natale,et al. Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. , 2001, Journal of the American College of Cardiology.

[1002] D. M. Taylor,et al. Antipsychotics and QT prolongation , 2003, Acta psychiatrica Scandinavica.

[1003] John Kattwinkel,et al. Changing Concepts of Sudden Infant Death Syndrome: Implications for Infant Sleeping Environment and Sleep Position , 2000, Pediatrics.

[1004] H. Fleming. Sarcoid heart disease. , 1974, British heart journal.

[1005] D. Nutt,et al. Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death , 2003, Journal of clinical psychopharmacology.

[1006] J. Mcanulty,et al. Idiopathic Dilated Cardiomyopathy : Role of Programmed Electrical Stimulation and Holter Monitoring in Predicting Those at Risk of Sudden Death , 1988 .

[1007] C. Funck-Brentano,et al. [Efficacy of high doses of molar lactate by the venous route in flecainide poisoning]. , 1987, Presse medicale.

[1008] A. Camm,et al. Study of cardiac rhythm in healthy newborn infants. , 1980, British heart journal.

[1009] J. Brugada,et al. Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator , 2004, Pacing and clinical electrophysiology : PACE.

[1010] M. Jonas,et al. Is immunosuppressive treatment an option for myocarditis? , 1997, Israel journal of medical sciences.

[1011] U Ravens,et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.

[1012] A. Moss,et al. Long QT Syndrome: An Indication for Cervicothoracic Sympathectomy , 1995, Cardiovascular surgery.

[1013] P. Meier,et al. Ventricular Arrhythmias and Sudden Cardiac Death in End-Stage Renal Disease Patients on Chronic Hemodialysis , 2001, Nephron.

[1014] R. Myerburg,et al. Scientific Gaps in the Prediction and Prevention of Sudden Cardiac Death , 2002, Journal of cardiovascular electrophysiology.

[1015] J. Sanderson,et al. Clinical profile of arrhythmogenic right ventricular cardiomyopathy in Chinese patients. , 2001, International journal of cardiology.

[1016] R Yee,et al. Randomized Assessment of Syncope Trial: Conventional Diagnostic Testing Versus a Prolonged Monitoring Strategy , 2001, Circulation.

[1017] C. Helmers,et al. Cardiac dysrhythmias in patients with acute myocardial infarction. Relation to serum potassium level and prior diuretic therapy. , 2009, Acta medica Scandinavica.

[1018] R. García-Civera,et al. Mechanism of Syncope in Patients With Heart Disease and Negative Electrophysiologic Test , 2002, Circulation.

[1019] T. Therneau,et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins , 2003, The Lancet.

[1020] C. Kawai,et al. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[1021] M. Link,et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[1022] P. Macfarlane,et al. Risk factors for sudden cardiac death in middle-aged British men. , 1995, Circulation.

[1023] S. Markowitz,et al. Prognostic Significance of Nonsustained Ventricular Tachycardia After Revascularization , 2002, Journal of cardiovascular electrophysiology.

[1024] I. Hulín,et al. Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters. , 2000, International journal of molecular medicine.

[1025] P. Lavori,et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. , 1997, Circulation.

[1026] Z. Tosun,et al. Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. , 1997, Journal of electrocardiology.

[1027] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[1028] G. Jondeau,et al. Left main coronary artery compression during primary pulmonary hypertension. , 1997, Chest.

[1029] S. Viskin,et al. Idiopathic Ventricular Tachycardia and Fibrillation , 1993, Journal of cardiovascular electrophysiology.

[1030] A. Hofman,et al. T-loop morphology as a marker of cardiac events in the elderly. , 1998, Journal of electrocardiology.

[1031] H Calkins,et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. , 1993, The American journal of cardiology.

[1032] Panos Vardas,et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. , 2003, European heart journal.

[1033] M. Reiter,et al. Importance of beta blockade in the therapy of serious ventricular arrhythmias. , 1998, The American journal of cardiology.

[1034] Louise Harris,et al. Congenital Heart Disease Left Ventricular Dysfunction Is a Risk Factor for Sudden Cardiac Death in Adults Late After Repair of Tetralogy of Fallot , 2002 .

[1035] C. Fuller. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. , 2000, Medicine and science in sports and exercise.

[1036] P. Dorian,et al. Hyperaldosteronism and sudden cardiac death. , 1996, The American journal of cardiology.

[1037] A. Camm,et al. Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification , 2004, Circulation.

[1038] M. Lauer,et al. Frequent ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.

[1039] J. Triedman,et al. Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease , 1999, Journal of cardiovascular electrophysiology.

[1040] H. Sakuraba,et al. Cardiovascular Manifestations in Fabry's Disease — Age‐Related Changes in Hemizygotes and Heterozygotes — , 1988, Acta paediatrica Japonica : Overseas edition.

[1041] D. Dawson,et al. Hypokalemic periodic paralysis with arrhythmia. , 1972, The New England journal of medicine.

[1042] L. McLain,et al. Sudden death in young athletes. , 2003, Pediatric annals.

[1043] A. Maggioni,et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. , 1996, Circulation.

[1044] S. Priori,et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. , 1999, The American journal of cardiology.

[1045] G. Klein,et al. Hemodynamic effects of intravenous procainamide during ventricular tachycardia. , 1990, American heart journal.

[1046] Akshay S. Desai,et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[1047] S. Markowitz,et al. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. , 1999, Journal of the American College of Cardiology.

[1048] C. Izumi,et al. Polymorphic ventricular tachycardia in a patient with adrenal insufficiency and hypothyroidism. , 1998, Japanese circulation journal.

[1049] J. Fernandez-Solà,et al. The Relation of Alcoholic Myopathy to Cardiomyopathy , 1994, Annals of Internal Medicine.

[1050] M. Josephson,et al. Hazards of intravenous verapamil for sustained ventricular tachycardia. , 1987, The American journal of cardiology.

[1051] A. Keren,et al. Magnesium therapy for torsades de pointes. , 1984, The American journal of cardiology.

[1052] T. Ashley. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. , 2001, Journal of insurance medicine.